{ "_what": "Every INN-named peptide whose highest ChEMBL phase is 2 or more, with its live status on ClinicalTrials.gov. Built by _ops/pipeline_data.py; read the docstring for what each field means and what the registry search cannot see.", "built": "2026-10-02", "read_from": "2026-10-01", "read_to": "2026-10-01", "counts": { "molecules": 331, "chembl_ids": 377, "with_active_study": 97, "in_encyclopedia": 78, "with_dated_readout": 97, "overdue_readouts": 5, "with_pdufa": 0 }, "rows": [ { "inn": "abaloparatide", "key": "abaloparatide", "chembl": "CHEMBL3301581", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301581/", "stem": "-tide", "usan_year": 2014, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": null, "mechanism": [ "Parathyroid hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3301581", "read": "2026-10-01", "active_studies": 6, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Hospital for Special Surgery, New York", "State University of New York at Buffalo", "Qilu Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=abaloparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03841058", "url": "https://clinicaltrials.gov/study/NCT03841058", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3301581" ], "chembl_names": [ "abaloparatide" ] }, { "inn": "carbetocin", "key": "carbetocin", "chembl": "CHEMBL3301668", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301668/", "stem": "-tocin", "usan_year": 2020, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": null, "encyclopedia": "carbetocin", "mechanism": [ "Oxytocin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3301668", "read": "2026-10-01", "active_studies": 14, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Sheba Medical Center", "Mansoura University", "Jordan Leitch" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=carbetocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-03-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07401524", "url": "https://clinicaltrials.gov/study/NCT07401524", "phase": "Phase 4", "status": "RECRUITING", "title": "Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3301668" ], "chembl_names": [ "carbetocin" ] }, { "inn": "cetrorelix", "key": "cetrorelix", "chembl": "CHEMBL1200490", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200490/", "stem": "-relix", "usan_year": 2000, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1999, "encyclopedia": "cetrorelix", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1200490", "read": "2026-10-01", "active_studies": 8, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany", "Trust Fertility Clinic", "Ahmed Saad" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cetrorelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07350317", "url": "https://clinicaltrials.gov/study/NCT07350317", "phase": "Phase 4", "status": "NOT_YET_RECRUITING", "title": "Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles.", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1200490", "CHEMBL2103735" ], "chembl_names": [ "cetrorelix", "cetrorelix acetate" ] }, { "inn": "degarelix", "key": "degarelix", "chembl": "CHEMBL415606", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL415606/", "stem": "-relix", "usan_year": 2007, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2008, "encyclopedia": "degarelix", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL415606", "read": "2026-10-01", "active_studies": 40, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "University of Colorado, Denver", "M.D. Anderson Cancer Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=degarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03951831", "url": "https://clinicaltrials.gov/study/NCT03951831", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL415606", "CHEMBL2028987" ], "chembl_names": [ "degarelix", "degarelix acetate" ] }, { "inn": "desmopressin", "key": "desmopressin", "chembl": "CHEMBL1429", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1429/", "stem": "-pressin", "usan_year": 1977, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1978, "encyclopedia": "desmopressin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1429", "read": "2026-10-01", "active_studies": 14, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Hospital de Clinicas de Porto Alegre", "Medical University of Bialystok", "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=desmopressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06337838", "url": "https://clinicaltrials.gov/study/NCT06337838", "phase": "Phase 3", "status": "RECRUITING", "title": "Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1429", "CHEMBL1200556" ], "chembl_names": [ "desmopressin", "desmopressin acetate" ] }, { "inn": "dulaglutide", "key": "dulaglutide", "chembl": "CHEMBL2108027", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108027/", "stem": "-tide", "usan_year": 2009, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2014, "encyclopedia": "dulaglutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108027", "read": "2026-10-01", "active_studies": 15, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Eli Lilly and Company", "National University of Singapore", "Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dulaglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06257966", "url": "https://clinicaltrials.gov/study/NCT06257966", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2108027" ], "chembl_names": [ "dulaglutide" ] }, { "inn": "efsubaglutide alfa", "key": "efsubaglutide alfa", "chembl": "CHEMBL6068241", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068241/", "stem": "ef-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068241", "read": "2026-10-01", "active_studies": 6, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.", "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=efsubaglutide+alfa&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07163650", "url": "https://clinicaltrials.gov/study/NCT07163650", "phase": "Phase 4", "status": "RECRUITING", "title": "Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068241" ], "chembl_names": [ "efsubaglutide alfa" ] }, { "inn": "elamipretide", "key": "elamipretide", "chembl": "CHEMBL3833370", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3833370/", "stem": "-tide", "usan_year": 2016, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "ss-31", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3833370", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Stealth BioTherapeutics Inc.", "David Marcinek" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=elamipretide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-08", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06373731", "url": "https://clinicaltrials.gov/study/NCT06373731", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3833370" ], "chembl_names": [ "elamipretide" ] }, { "inn": "exenatide", "key": "exenatide", "chembl": "CHEMBL414357", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL414357/", "stem": "-tide", "usan_year": 2003, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2005, "encyclopedia": "exenatide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL414357", "read": "2026-10-01", "active_studies": 8, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Seattle Children's Hospital", "Maisa N. Feghali, MD", "CellTrans Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=exenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2025-12-31", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT05482789", "url": "https://clinicaltrials.gov/study/NCT05482789", "phase": "Phase 4", "status": "RECRUITING", "title": "Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL414357" ], "chembl_names": [ "exenatide" ] }, { "inn": "ganirelix", "key": "ganirelix", "chembl": "CHEMBL1251", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1251/", "stem": "-relix", "usan_year": 1991, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1999, "encyclopedia": "ganirelix", "mechanism": [ "Gonadotropin-releasing hormone receptor antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1251", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "University of Delaware" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ganirelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06745466", "url": "https://clinicaltrials.gov/study/NCT06745466", "phase": "Phase 4", "status": "RECRUITING", "title": "Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1251", "CHEMBL5314377" ], "chembl_names": [ "ganirelix", "ganirelix acetate" ] }, { "inn": "goserelin", "key": "goserelin", "chembl": "CHEMBL1201247", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201247/", "stem": "-relin", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1989, "encyclopedia": "goserelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201247", "read": "2026-10-01", "active_studies": 69, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "City of Hope Medical Center", "Fudan University", "NRG Oncology" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=goserelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05607004", "url": "https://clinicaltrials.gov/study/NCT05607004", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201247", "CHEMBL1200501" ], "chembl_names": [ "goserelin", "goserelin acetate" ] }, { "inn": "lanreotide", "key": "lanreotide", "chembl": "CHEMBL1201185", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201185/", "stem": "-tide", "usan_year": 1992, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2007, "encyclopedia": "lanreotide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201185", "read": "2026-10-01", "active_studies": 8, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Grupo Espanol de Tumores Neuroendocrinos", "Antonio Fojo", "Camurus AB" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lanreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05050942", "url": "https://clinicaltrials.gov/study/NCT05050942", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201185", "CHEMBL1201184" ], "chembl_names": [ "lanreotide", "lanreotide acetate" ] }, { "inn": "linaclotide", "key": "linaclotide", "chembl": "CHEMBL3301675", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301675/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2012, "encyclopedia": "linaclotide", "mechanism": [ "Heat-stable enterotoxin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3301675", "read": "2026-10-01", "active_studies": 7, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "University of Florida", "Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University", "Texas Tech University Health Sciences Center, El Paso" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=linaclotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03119584", "url": "https://clinicaltrials.gov/study/NCT03119584", "phase": "Phase 4", "status": "ACTIVE_NOT_RECRUITING", "title": "Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3301675", "CHEMBL3301676" ], "chembl_names": [ "linaclotide", "linaclotide acetate" ] }, { "inn": "liraglutide", "key": "liraglutide", "chembl": "CHEMBL4084119", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4084119/", "stem": "-tide", "usan_year": 2007, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2009, "encyclopedia": "liraglutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4084119", "read": "2026-10-01", "active_studies": 30, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "University of Virginia", "4Moving Biotech", "Biolingus" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=liraglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03856632", "url": "https://clinicaltrials.gov/study/NCT03856632", "phase": "Phase 4", "status": "ACTIVE_NOT_RECRUITING", "title": "Liraglutide Effect in Atrial Fibrillation", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4084119" ], "chembl_names": [ "liraglutide" ] }, { "inn": "lixisenatide", "key": "lixisenatide", "chembl": "CHEMBL2108336", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108336/", "stem": "-tide", "usan_year": 2013, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2013, "encyclopedia": "lixisenatide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108336", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Yanbing Li", "Sanofi", "Medical University of Warsaw" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lixisenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07173712", "url": "https://clinicaltrials.gov/study/NCT07173712", "phase": "Phase 4", "status": "NOT_YET_RECRUITING", "title": "Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2108336" ], "chembl_names": [ "lixisenatide" ] }, { "inn": "mazdutide", "key": "mazdutide", "chembl": "CHEMBL5095358", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095358/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "mazdutide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095358", "read": "2026-10-01", "active_studies": 16, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "West China Hospital", "Tongji Hospital", "Fujian Shengdi Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mazdutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-04", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07843862", "url": "https://clinicaltrials.gov/study/NCT07843862", "phase": "Phase 2", "status": "NOT_YET_RECRUITING", "title": "A Study of HRS-4729 Injection in Participants With Type 2 Diabetes", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095358" ], "chembl_names": [ "mazdutide" ] }, { "inn": "motixafortide", "key": "motixafortide", "chembl": "CHEMBL5095030", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095030/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2023, "encyclopedia": null, "mechanism": [ "C-X-C chemokine receptor type 4 antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095030", "read": "2026-10-01", "active_studies": 6, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Guangzhou Gloria Biosciences Co., Ltd.", "Emory University", "Columbia University" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=motixafortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07101445", "url": "https://clinicaltrials.gov/study/NCT07101445", "phase": "Phase 4", "status": "RECRUITING", "title": "Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095030", "CHEMBL5095449" ], "chembl_names": [ "motixafortide", "motixafortide acetate" ] }, { "inn": "nafarelin", "key": "nafarelin", "chembl": "CHEMBL1201309", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201309/", "stem": "-relin", "usan_year": 1984, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1990, "encyclopedia": "nafarelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201309", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Fundacion Dexeus", "Assistance Publique - Hôpitaux de Paris" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nafarelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-09", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06150703", "url": "https://clinicaltrials.gov/study/NCT06150703", "phase": "Phase 3", "status": "RECRUITING", "title": "Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201309", "CHEMBL1200671" ], "chembl_names": [ "nafarelin", "nafarelin acetate" ] }, { "inn": "octreotide", "key": "octreotide", "chembl": "CHEMBL1680", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1680/", "stem": "-tide", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1988, "encyclopedia": "octreotide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1680", "read": "2026-10-01", "active_studies": 34, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "Camurus AB", "Grupo Espanol de Tumores Neuroendocrinos" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=octreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05050942", "url": "https://clinicaltrials.gov/study/NCT05050942", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1680", "CHEMBL1200480", "CHEMBL2105834", "CHEMBL3545066" ], "chembl_names": [ "octreotide", "octreotide acetate", "octreotide pamoate", "octreotide hydrochloride" ] }, { "inn": "oxytocin", "key": "oxytocin", "chembl": "CHEMBL395429", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL395429/", "stem": "-tocin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1980, "encyclopedia": "oxytocin", "mechanism": [ "Oxytocin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL395429", "read": "2026-10-01", "active_studies": 81, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "University Hospital, Basel, Switzerland", "Wake Forest University Health Sciences", "Yale University" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=oxytocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06036004", "url": "https://clinicaltrials.gov/study/NCT06036004", "phase": "Phase 2", "status": "RECRUITING", "title": "Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL395429" ], "chembl_names": [ "oxytocin" ] }, { "inn": "pasireotide", "key": "pasireotide", "chembl": "CHEMBL3349607", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3349607/", "stem": "-tide", "usan_year": 2011, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2012, "encyclopedia": "pasireotide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3349607", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "University Hospital Heidelberg", "Helsinki University Central Hospital", "Memorial Sloan Kettering Cancer Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pasireotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-29", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05928390", "url": "https://clinicaltrials.gov/study/NCT05928390", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3349607", "CHEMBL5314382" ], "chembl_names": [ "pasireotide", "pasireotide pamoate" ] }, { "inn": "semaglutide", "key": "semaglutide", "chembl": "CHEMBL2108724", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108724/", "stem": "-tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": "semaglutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108724", "read": "2026-10-01", "active_studies": 280, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Novo Nordisk A/S", "Mayo Clinic", "The University of Texas Health Science Center, Houston" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=semaglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-15", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07505303", "url": "https://clinicaltrials.gov/study/NCT07505303", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2108724" ], "chembl_names": [ "semaglutide" ] }, { "inn": "setmelanotide", "key": "setmelanotide", "chembl": "CHEMBL3301624", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301624/", "stem": "-tide", "usan_year": 2014, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2020, "encyclopedia": "setmelanotide", "mechanism": [ "Melanocortin receptor 4 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3301624", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Rhythm Pharmaceuticals, Inc.", "Massachusetts General Hospital", "Tom Hühne" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=setmelanotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06772597", "url": "https://clinicaltrials.gov/study/NCT06772597", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study of Setmelanotide in Patients With Prader-Willi Syndrome", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3301624", "CHEMBL4650273" ], "chembl_names": [ "setmelanotide", "setmelanotide acetate" ] }, { "inn": "teriparatide", "key": "teriparatide", "chembl": "CHEMBL525610", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL525610/", "stem": "-tide", "usan_year": 1996, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1987, "encyclopedia": "teriparatide", "mechanism": [ "Parathyroid hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL525610", "read": "2026-10-01", "active_studies": 14, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Ditte Hansen", "Massachusetts General Hospital", "University of South Carolina" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=teriparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT04589819", "url": "https://clinicaltrials.gov/study/NCT04589819", "phase": "Phase 4", "status": "ENROLLING_BY_INVITATION", "title": "Fracture Recovery for Returning to Duty (Teriparatide STRONG)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL525610", "CHEMBL1201549" ], "chembl_names": [ "teriparatide", "teriparatide acetate" ] }, { "inn": "tirzepatide", "key": "tirzepatide", "chembl": "CHEMBL4297839", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297839/", "stem": "-tide", "usan_year": 2017, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2022, "encyclopedia": "tirzepatide", "mechanism": [ "Gastric inhibitory polypeptide receptor agonist", "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297839", "read": "2026-10-01", "active_studies": 162, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Eli Lilly and Company", "Mayo Clinic", "The Cleveland Clinic" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tirzepatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06861439", "url": "https://clinicaltrials.gov/study/NCT06861439", "phase": "Phase 4", "status": "ACTIVE_NOT_RECRUITING", "title": "GLP-1s to Enhance Lasting Optimal Weight", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297839" ], "chembl_names": [ "tirzepatide" ] }, { "inn": "triptorelin", "key": "triptorelin", "chembl": "CHEMBL1201334", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201334/", "stem": "-relin", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2000, "encyclopedia": "triptorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201334", "read": "2026-10-01", "active_studies": 36, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "H. Lee Moffitt Cancer Center and Research Institute", "NRG Oncology", "ECOG-ACRIN Cancer Research Group" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=triptorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05050084", "url": "https://clinicaltrials.gov/study/NCT05050084", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201334", "CHEMBL1200554", "CHEMBL5315073" ], "chembl_names": [ "triptorelin", "triptorelin pamoate", "triptorelin acetate" ] }, { "inn": "vasopressin", "key": "vasopressin", "chembl": "CHEMBL373742", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL373742/", "stem": "-pressin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2014, "encyclopedia": "vasopressin", "mechanism": [ "Vasopressin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL373742", "read": "2026-10-01", "active_studies": 29, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Hospital do Coracao", "Assistance Publique - Hôpitaux de Paris", "University of California, Los Angeles" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vasopressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT02118467", "url": "https://clinicaltrials.gov/study/NCT02118467", "phase": "Phase 4", "status": "RECRUITING", "title": "Vasoactive Drugs in Intensive Care Unit", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL373742" ], "chembl_names": [ "vasopressin" ] }, { "inn": "vipivotide tetraxetan", "key": "vipivotide tetraxetan", "chembl": "CHEMBL4594280", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594280/", "stem": "-tide; -xetan", "usan_year": 2019, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2022, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4594280", "read": "2026-10-01", "active_studies": 38, "most_advanced_active_phase": "Phase 4", "lead_sponsors": [ "Novartis Pharmaceuticals", "University of Washington", "Jonsson Comprehensive Cancer Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vipivotide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-15", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06894511", "url": "https://clinicaltrials.gov/study/NCT06894511", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4594280", "CHEMBL4594406" ], "chembl_names": [ "vipivotide tetraxetan", "lutetium lu-177 vipivotide tetraxetan" ] }, { "inn": "afamelanotide", "key": "afamelanotide", "chembl": "CHEMBL441738", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL441738/", "stem": "-tide", "usan_year": 2017, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2014, "encyclopedia": "afamelanotide", "mechanism": [ "Melanocortin receptor 1 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL441738", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Clinuvel, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=afamelanotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2025-12", "date_type": "ESTIMATED", "state": "estimate-lapsed", "overdue": true, "nct": "NCT06109649", "url": "https://clinicaltrials.gov/study/NCT06109649", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL441738", "CHEMBL4297213" ], "chembl_names": [ "afamelanotide", "afamelanotide acetate" ] }, { "inn": "anamorelin", "key": "anamorelin", "chembl": "CHEMBL2110579", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110579/", "stem": "-relin", "usan_year": 2007, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "anamorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2110579", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "M.D. Anderson Cancer Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=anamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03637816", "url": "https://clinicaltrials.gov/study/NCT03637816", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2110579", "CHEMBL2103794" ], "chembl_names": [ "anamorelin", "anamorelin hydrochloride" ] }, { "inn": "avexitide", "key": "avexitide", "chembl": "CHEMBL4297949", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297949/", "stem": "-tide", "usan_year": 2018, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Glucagon-like peptide 1 receptor antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297949", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Amylyx Pharmaceuticals Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=avexitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-07-08", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT06747468", "url": "https://clinicaltrials.gov/study/NCT06747468", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Avexitide for Treatment of Post-Bariatric Hypoglycemia", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297949" ], "chembl_names": [ "avexitide" ] }, { "inn": "bofanglutide", "key": "bofanglutide", "chembl": "CHEMBL6068096", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068096/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068096", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Carnot Laboratories" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=bofanglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07628985", "url": "https://clinicaltrials.gov/study/NCT07628985", "phase": "Phase 3", "status": "NOT_YET_RECRUITING", "title": "BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068096" ], "chembl_names": [ "bofanglutide" ] }, { "inn": "bulevirtide", "key": "bulevirtide", "chembl": "CHEMBL4297711", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297711/", "stem": "-tide; -vir-", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2020, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297711", "read": "2026-10-01", "active_studies": 10, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Vir Biotechnology, Inc.", "Mirum Pharmaceuticals, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=bulevirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07142811", "url": "https://clinicaltrials.gov/study/NCT07142811", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297711", "CHEMBL5315080" ], "chembl_names": [ "bulevirtide", "bulevirtide acetate" ] }, { "inn": "buserelin", "key": "buserelin", "chembl": "CHEMBL2110824", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110824/", "stem": "-relin", "usan_year": 1979, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": null, "encyclopedia": "buserelin", "mechanism": [ "Gonadotropin-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2110824", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "NRG Oncology", "Proton Collaborative Group" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=buserelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05050084", "url": "https://clinicaltrials.gov/study/NCT05050084", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2110824", "CHEMBL2106198" ], "chembl_names": [ "buserelin", "buserelin acetate" ] }, { "inn": "cagrilintide", "key": "cagrilintide", "chembl": "CHEMBL4802169", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802169/", "stem": "-tide", "usan_year": 2022, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "cagrilintide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4802169", "read": "2026-10-01", "active_studies": 16, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Novo Nordisk A/S" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cagrilintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-03-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07011667", "url": "https://clinicaltrials.gov/study/NCT07011667", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4802169" ], "chembl_names": [ "cagrilintide" ] }, { "inn": "canvuparatide", "key": "canvuparatide", "chembl": "CHEMBL6068219", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068219/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068219", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "MBX Biosciences" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=canvuparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07699471", "url": "https://clinicaltrials.gov/study/NCT07699471", "phase": "Phase 3", "status": "RECRUITING", "title": "A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068219" ], "chembl_names": [ "canvuparatide" ] }, { "inn": "ecnoglutide", "key": "ecnoglutide", "chembl": "CHEMBL5095115", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095115/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "ecnoglutide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095115", "read": "2026-10-01", "active_studies": 7, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Hangzhou Sciwind Biosciences Co., Ltd.", "Verdiva Bio Dev Limited" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ecnoglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07553299", "url": "https://clinicaltrials.gov/study/NCT07553299", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095115" ], "chembl_names": [ "ecnoglutide" ] }, { "inn": "edotreotide", "key": "edotreotide", "chembl": "CHEMBL408350", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408350/", "stem": "-tide", "usan_year": 2002, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL408350", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "ITM Solucin GmbH", "Grupo Espanol de Tumores Neuroendocrinos" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT04919226", "url": "https://clinicaltrials.gov/study/NCT04919226", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL408350", "CHEMBL5095425" ], "chembl_names": [ "edotreotide", "lutetium lu177 edotreotide" ] }, { "inn": "eloralintide", "key": "eloralintide", "chembl": "CHEMBL6068462", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068462/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "eloralintide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068462", "read": "2026-10-01", "active_studies": 15, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Eli Lilly and Company" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=eloralintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-03", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07215559", "url": "https://clinicaltrials.gov/study/NCT07215559", "phase": "Phase 2", "status": "RECRUITING", "title": "A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068462" ], "chembl_names": [ "eloralintide" ] }, { "inn": "eneboparatide", "key": "eneboparatide", "chembl": "CHEMBL5095311", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095311/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095311", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Alexion Pharmaceuticals, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=eneboparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2024-11-15", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT05778071", "url": "https://clinicaltrials.gov/study/NCT05778071", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095311" ], "chembl_names": [ "eneboparatide" ] }, { "inn": "enlicitide", "key": "enlicitide", "chembl": "CHEMBL6068773", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068773/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "enlicitide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068773", "read": "2026-10-01", "active_studies": 8, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Merck Sharp & Dohme LLC" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=enlicitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07614984", "url": "https://clinicaltrials.gov/study/NCT07614984", "phase": "Phase 2", "status": "RECRUITING", "title": "A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068773" ], "chembl_names": [ "enlicitide" ] }, { "inn": "enlicitide decanoate", "key": "enlicitide decanoate", "chembl": "CHEMBL6068420", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068420/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "enlicitide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068420", "read": "2026-10-01", "active_studies": 7, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Merck Sharp & Dohme LLC" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=enlicitide+decanoate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07614984", "url": "https://clinicaltrials.gov/study/NCT07614984", "phase": "Phase 2", "status": "RECRUITING", "title": "A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068420" ], "chembl_names": [ "enlicitide decanoate" ] }, { "inn": "eptifibatide", "key": "eptifibatide", "chembl": "CHEMBL1174", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1174/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1998, "encyclopedia": "eptifibatide", "mechanism": [ "Integrin alpha-IIb/beta-3 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1174", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Xinqiao Hospital of Chongqing" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=eptifibatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2029-09-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07347626", "url": "https://clinicaltrials.gov/study/NCT07347626", "phase": "Phase 3", "status": "NOT_YET_RECRUITING", "title": "Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1174" ], "chembl_names": [ "eptifibatide" ] }, { "inn": "etelcalcetide", "key": "etelcalcetide", "chembl": "CHEMBL3545184", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545184/", "stem": "-tide", "usan_year": 2012, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2016, "encyclopedia": null, "mechanism": [ "Calcium sensing receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545184", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Amgen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=etelcalcetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT03969329", "url": "https://clinicaltrials.gov/study/NCT03969329", "phase": "Phase 3", "status": "RECRUITING", "title": "A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3545184", "CHEMBL3545183" ], "chembl_names": [ "etelcalcetide", "etelcalcetide hydrochloride" ] }, { "inn": "glepaglutide", "key": "glepaglutide", "chembl": "CHEMBL4297761", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297761/", "stem": "-tide", "usan_year": 2017, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "glepaglutide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297761", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Zealand Pharma" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=glepaglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-09-18", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07228403", "url": "https://clinicaltrials.gov/study/NCT07228403", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297761" ], "chembl_names": [ "glepaglutide" ] }, { "inn": "gonadorelin", "key": "gonadorelin", "chembl": "CHEMBL1007", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1007/", "stem": "-relin", "usan_year": 1975, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1982, "encyclopedia": "gonadorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1007", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Nelly Pitteloud" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gonadorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT04390646", "url": "https://clinicaltrials.gov/study/NCT04390646", "phase": "Phase 3", "status": "RECRUITING", "title": "GnRH Therapy on Cognition in Down Syndrome", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1007", "CHEMBL1200511", "CHEMBL1200516" ], "chembl_names": [ "gonadorelin", "gonadorelin acetate", "gonadorelin hydrochloride" ] }, { "inn": "gozetotide", "key": "gozetotide", "chembl": "CHEMBL3578202", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3578202/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Small molecule", "chembl_max_phase": 4.0, "first_approval": 2020, "encyclopedia": null, "mechanism": [ "Diagnostic agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3578202", "read": "2026-10-01", "active_studies": 12, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Jonsson Comprehensive Cancer Center", "Fred Hutchinson Cancer Center", "Novartis Pharmaceuticals" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gozetotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06145633", "url": "https://clinicaltrials.gov/study/NCT06145633", "phase": "Phase 2", "status": "RECRUITING", "title": "Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3578202", "CHEMBL5095039" ], "chembl_names": [ "gozetotide", "gallium ga 68 gozetotide" ] }, { "inn": "hepalatide", "key": "hepalatide", "chembl": "CHEMBL4650398", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650398/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Bile acid transporter inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650398", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Shanghai HEP Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=hepalatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07309380", "url": "https://clinicaltrials.gov/study/NCT07309380", "phase": "Phase 3", "status": "NOT_YET_RECRUITING", "title": "Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4650398" ], "chembl_names": [ "hepalatide" ] }, { "inn": "histrelin", "key": "histrelin", "chembl": "CHEMBL1201255", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201255/", "stem": "-relin", "usan_year": 1985, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1991, "encyclopedia": "histrelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201255", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "NRG Oncology", "VA Office of Research and Development", "SWOG Cancer Research Network" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=histrelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05050084", "url": "https://clinicaltrials.gov/study/NCT05050084", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201255", "CHEMBL1200509" ], "chembl_names": [ "histrelin", "histrelin acetate" ] }, { "inn": "lutetium lu 177 zadavotide guraxetan", "key": "zadavotide guraxetan", "chembl": "CHEMBL5314936", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314936/", "stem": "-tide; -xetan", "usan_year": 2024, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314936", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "AstraZeneca" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zadavotide+guraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2029-06-04", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07611110", "url": "https://clinicaltrials.gov/study/NCT07611110", "phase": "Phase 3", "status": "RECRUITING", "title": "AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314936" ], "chembl_names": [ "lutetium lu 177 zadavotide guraxetan" ] }, { "inn": "maridebart cafraglutide", "key": "maridebart cafraglutide", "chembl": "CHEMBL5314751", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314751/", "stem": "-bart; -tide", "usan_year": null, "molecule_type": "Antibody drug conjugate", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "maridebart-cafraglutide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314751", "read": "2026-10-01", "active_studies": 15, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Amgen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=maridebart+cafraglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-01-21", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06858878", "url": "https://clinicaltrials.gov/study/NCT06858878", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314751" ], "chembl_names": [ "maridebart cafraglutide" ] }, { "inn": "palopegteriparatide", "key": "palopegteriparatide", "chembl": "CHEMBL5095475", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095475/", "stem": "-peg-; -tide", "usan_year": 2022, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2023, "encyclopedia": null, "mechanism": [ "Parathyroid hormone receptor agonist", "Parathyroid hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095475", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Ascendis Pharma Bone Diseases A/S", "Ascendis Pharma A/S" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=palopegteriparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07081997", "url": "https://clinicaltrials.gov/study/NCT07081997", "phase": "Phase 3", "status": "RECRUITING", "title": "A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095475" ], "chembl_names": [ "palopegteriparatide" ] }, { "inn": "pemvidutide", "key": "pemvidutide", "chembl": "CHEMBL5095142", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095142/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "pemvidutide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095142", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Altimmune, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pemvidutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-09-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07009860", "url": "https://clinicaltrials.gov/study/NCT07009860", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095142" ], "chembl_names": [ "pemvidutide" ] }, { "inn": "petrelintide", "key": "petrelintide", "chembl": "CHEMBL5314864", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314864/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "petrelintide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314864", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Hoffmann-La Roche" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=petrelintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-11-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07589686", "url": "https://clinicaltrials.gov/study/NCT07589686", "phase": "Phase 2", "status": "NOT_YET_RECRUITING", "title": "A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314864" ], "chembl_names": [ "petrelintide" ] }, { "inn": "retatrutide", "key": "retatrutide", "chembl": "CHEMBL5095485", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095485/", "stem": "-tide", "usan_year": 2022, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "retatrutide", "mechanism": [ "Glucagon receptor agonist", "Glucagon-like peptide 1 receptor agonist", "Gastric inhibitory polypeptide receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095485", "read": "2026-10-01", "active_studies": 11, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Eli Lilly and Company", "Hudson Biotech" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=retatrutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06297603", "url": "https://clinicaltrials.gov/study/NCT06297603", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5095485" ], "chembl_names": [ "retatrutide" ] }, { "inn": "rusfertide", "key": "rusfertide", "chembl": "CHEMBL4650507", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650507/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "rusfertide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650507", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Takeda", "Protagonist Therapeutics, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rusfertide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10-28", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07648030", "url": "https://clinicaltrials.gov/study/NCT07648030", "phase": "Phase 2", "status": "RECRUITING", "title": "A Study of Rusfertide in Japanese Adults With Polycythemia Vera", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4650507" ], "chembl_names": [ "rusfertide" ] }, { "inn": "survodutide", "key": "survodutide", "chembl": "CHEMBL5314776", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314776/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "survodutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist", "Glucagon receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314776", "read": "2026-10-01", "active_studies": 10, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Boehringer Ingelheim", "University Medical Center Groningen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=survodutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-11-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07206290", "url": "https://clinicaltrials.gov/study/NCT07206290", "phase": "Phase 2", "status": "NOT_YET_RECRUITING", "title": "Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314776" ], "chembl_names": [ "survodutide" ] }, { "inn": "teduglutide", "key": "teduglutide", "chembl": "CHEMBL2104987", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104987/", "stem": "-tide", "usan_year": 2000, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2012, "encyclopedia": "teduglutide", "mechanism": [ "Glucagon-like peptide 2 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104987", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "International Centre for Diarrhoeal Disease Research, Bangladesh", "Takeda" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=teduglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-02-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06973304", "url": "https://clinicaltrials.gov/study/NCT06973304", "phase": "Phase 3", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2104987" ], "chembl_names": [ "teduglutide" ] }, { "inn": "terlipressin", "key": "terlipressin", "chembl": "CHEMBL2135460", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2135460/", "stem": "-pressin", "usan_year": 2006, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2022, "encyclopedia": "terlipressin", "mechanism": [ "Vasopressin V1 receptor binding agent", "Vasopressin V2 receptor binding agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2135460", "read": "2026-10-01", "active_studies": 9, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Noorik Biopharmaceuticals AG", "Institute of Liver and Biliary Sciences, India" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=terlipressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-05", "date_type": "ESTIMATED", "state": "estimate-lapsed", "overdue": true, "nct": "NCT06256432", "url": "https://clinicaltrials.gov/study/NCT06256432", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2135460" ], "chembl_names": [ "terlipressin" ] }, { "inn": "tertomotide", "key": "tertomotide", "chembl": "CHEMBL2108308", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108308/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108308", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "Samsung Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tertomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05303701", "url": "https://clinicaltrials.gov/study/NCT05303701", "phase": "Phase 3", "status": "NOT_YET_RECRUITING", "title": "GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2108308" ], "chembl_names": [ "tertomotide" ] }, { "inn": "vosoritide", "key": "vosoritide", "chembl": "CHEMBL3707276", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707276/", "stem": "-tide", "usan_year": 2016, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2021, "encyclopedia": "vosoritide", "mechanism": [ "Atrial natriuretic peptide receptor B binding agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3707276", "read": "2026-10-01", "active_studies": 13, "most_advanced_active_phase": "Phase 3", "lead_sponsors": [ "BioMarin Pharmaceutical", "Andrew Dauber", "Roopa Kanakatti Shankar, MBBS, MS" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vosoritide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-03", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06668805", "url": "https://clinicaltrials.gov/study/NCT06668805", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL3707276" ], "chembl_names": [ "vosoritide" ] }, { "inn": "bremelanotide", "key": "bremelanotide", "chembl": "CHEMBL2070241", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2070241/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2019, "encyclopedia": "pt-141", "mechanism": [ "Melanocortin receptor 4 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2070241", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Palatin Technologies, Inc" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=bremelanotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2025-02-05", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT06565611", "url": "https://clinicaltrials.gov/study/NCT06565611", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2070241", "CHEMBL4297533" ], "chembl_names": [ "bremelanotide", "bremelanotide acetate" ] }, { "inn": "certepetide", "key": "certepetide", "chembl": "CHEMBL5315026", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5315026/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5315026", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Anup Kasi", "Qilu Pharmaceutical Co., Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=certepetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2025-09", "date_type": "ESTIMATED", "state": "estimate-lapsed", "overdue": true, "nct": "NCT05121038", "url": "https://clinicaltrials.gov/study/NCT05121038", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5315026" ], "chembl_names": [ "certepetide" ] }, { "inn": "dapiglutide", "key": "dapiglutide", "chembl": "CHEMBL5314980", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314980/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314980", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "University Hospital, Gentofte, Copenhagen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dapiglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2024-04-24", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT05788601", "url": "https://clinicaltrials.gov/study/NCT05788601", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Dapiglutide for the Treatment of Obesity", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314980" ], "chembl_names": [ "dapiglutide" ] }, { "inn": "gallium oxodotreotide", "key": "gallium oxodotreotide", "chembl": "CHEMBL262135", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL262135/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2016, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL262135", "read": "2026-10-01", "active_studies": 6, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "OHSU Knight Cancer Institute", "Mayo Clinic", "Joshua Palmer" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gallium+oxodotreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05691465", "url": "https://clinicaltrials.gov/study/NCT05691465", "phase": "Phase 2", "status": "RECRUITING", "title": "Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL262135" ], "chembl_names": [ "gallium oxodotreotide" ] }, { "inn": "ghrelin", "key": "ghrelin", "chembl": "CHEMBL500468", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL500468/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "ghrelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL500468", "read": "2026-10-01", "active_studies": 5, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Charles University, Czech Republic" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ghrelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2007-12-16", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT03338387", "url": "https://clinicaltrials.gov/study/NCT03338387", "phase": "Phase 2", "status": "ENROLLING_BY_INVITATION", "title": "Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL500468" ], "chembl_names": [ "ghrelin" ] }, { "inn": "lsalt peptide", "key": "lsalt peptide", "chembl": "CHEMBL5314991", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314991/", "stem": "-sal-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314991", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Arch Biopartners Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lsalt+peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-03", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05879432", "url": "https://clinicaltrials.gov/study/NCT05879432", "phase": "Phase 2", "status": "RECRUITING", "title": "LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314991" ], "chembl_names": [ "lsalt peptide" ] }, { "inn": "lutetium oxodotreotide", "key": "lutetium oxodotreotide", "chembl": "CHEMBL4302409", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4302409/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4302409", "read": "2026-10-01", "active_studies": 10, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "National Cancer Institute (NCI)", "OHSU Knight Cancer Institute", "Mayo Clinic" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+oxodotreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05691465", "url": "https://clinicaltrials.gov/study/NCT05691465", "phase": "Phase 2", "status": "RECRUITING", "title": "Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4302409" ], "chembl_names": [ "lutetium oxodotreotide" ] }, { "inn": "lutetium oxodotreotide lu-177", "key": "lutetium oxodotreotide lu-177", "chembl": "CHEMBL4297545", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297545/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": null, "mechanism": [ "Somatostatin receptor binding agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297545", "read": "2026-10-01", "active_studies": 10, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "National Cancer Institute (NCI)", "OHSU Knight Cancer Institute", "Mayo Clinic" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+oxodotreotide+lu-177&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05691465", "url": "https://clinicaltrials.gov/study/NCT05691465", "phase": "Phase 2", "status": "RECRUITING", "title": "Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297545" ], "chembl_names": [ "lutetium oxodotreotide lu-177" ] }, { "inn": "mifamurtide", "key": "mifamurtide", "chembl": "CHEMBL2107354", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107354/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Small molecule", "chembl_max_phase": 4.0, "first_approval": 2009, "encyclopedia": null, "mechanism": [ "Nucleotide-binding oligomerization domain-containing protein 2 other" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107354", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "UNICANCER", "Anna Raciborska" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mifamurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2033-07-31", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07787429", "url": "https://clinicaltrials.gov/study/NCT07787429", "phase": "Phase 2", "status": "RECRUITING", "title": "Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2107354" ], "chembl_names": [ "mifamurtide" ] }, { "inn": "mifomelatide", "key": "mifomelatide", "chembl": "CHEMBL6068142", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068142/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068142", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Endevica Bio" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mifomelatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06937177", "url": "https://clinicaltrials.gov/study/NCT06937177", "phase": "Phase 2", "status": "RECRUITING", "title": "Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068142" ], "chembl_names": [ "mifomelatide" ] }, { "inn": "nangibotide", "key": "nangibotide", "chembl": "CHEMBL4297793", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297793/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Triggering receptor expressed on myeloid cells 1 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297793", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Inotrem" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nangibotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2022-05-09", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT04055909", "url": "https://clinicaltrials.gov/study/NCT04055909", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297793" ], "chembl_names": [ "nangibotide" ] }, { "inn": "navepegritide", "key": "navepegritide", "chembl": "CHEMBL4594507", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594507/", "stem": "-peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "navepegritide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4594507", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Ascendis Pharma A/S", "Ascendis Pharma Growth Disorders A/S" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=navepegritide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-08", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06732895", "url": "https://clinicaltrials.gov/study/NCT06732895", "phase": "Phase 2", "status": "RECRUITING", "title": "A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4594507" ], "chembl_names": [ "navepegritide" ] }, { "inn": "nesiritide", "key": "nesiritide", "chembl": "CHEMBL1201668", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201668/", "stem": "-tide", "usan_year": 1998, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2001, "encyclopedia": "nesiritide", "mechanism": [ "Atrial natriuretic peptide receptor A agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201668", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Oslo University Hospital" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nesiritide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2018-12", "date_type": "ESTIMATED", "state": "estimate-lapsed", "overdue": true, "nct": "NCT02608996", "url": "https://clinicaltrials.gov/study/NCT02608996", "phase": "Phase 2", "status": "RECRUITING", "title": "Nesiritide in Hypertension", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1201668" ], "chembl_names": [ "nesiritide" ] }, { "inn": "olatorepatide", "key": "olatorepatide", "chembl": "CHEMBL6068153", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068153/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068153", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Regeneron Pharmaceuticals" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=olatorepatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-11-13", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07431086", "url": "https://clinicaltrials.gov/study/NCT07431086", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068153" ], "chembl_names": [ "olatorepatide" ] }, { "inn": "pasireotide diaspartate", "key": "pasireotide diaspartate", "chembl": "CHEMBL5314380", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314380/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2012, "encyclopedia": null, "mechanism": [ "Somatostatin receptor 5 agonist", "Somatostatin receptor 2 agonist", "Somatostatin receptor 1 agonist", "Somatostatin receptor 3 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314380", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "RECORDATI GROUP" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pasireotide+diaspartate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10-29", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT05928390", "url": "https://clinicaltrials.gov/study/NCT05928390", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314380" ], "chembl_names": [ "pasireotide diaspartate" ] }, { "inn": "plecanatide", "key": "plecanatide", "chembl": "CHEMBL2103867", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103867/", "stem": "-tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": "plecanatide", "mechanism": [ "Heat-stable enterotoxin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103867", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Bausch Health Americas, Inc." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=plecanatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-10-18", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07723924", "url": "https://clinicaltrials.gov/study/NCT07723924", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2103867" ], "chembl_names": [ "plecanatide" ] }, { "inn": "sonefpeglutide", "key": "sonefpeglutide", "chembl": "CHEMBL6068175", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068175/", "stem": "-peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068175", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Hanmi Pharmaceutical Company Limited" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sonefpeglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-12", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT04775706", "url": "https://clinicaltrials.gov/study/NCT04775706", "phase": "Phase 2", "status": "RECRUITING", "title": "Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL6068175" ], "chembl_names": [ "sonefpeglutide" ] }, { "inn": "svn53-67/m57-klh peptide vaccine", "key": "svn53-67/m57-klh peptide vaccine", "chembl": "CHEMBL4650424", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650424/", "stem": "-tide", "usan_year": null, "molecule_type": "Vaccine component", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Hemocyanin 1 vaccine antigen", "Baculoviral IAP repeat-containing protein 5 vaccine antigen" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650424", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Roswell Park Cancer Institute", "National Cancer Institute (NCI)" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=svn53-67%2Fm57-klh+peptide+vaccine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2029-03-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07169617", "url": "https://clinicaltrials.gov/study/NCT07169617", "phase": "Phase 2", "status": "NOT_YET_RECRUITING", "title": "Testing the SurVaxM Vaccine for Lung Cancer Prevention", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4650424" ], "chembl_names": [ "svn53-67/m57-klh peptide vaccine" ] }, { "inn": "tesamorelin", "key": "tesamorelin", "chembl": "CHEMBL1237026", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237026/", "stem": "-relin", "usan_year": 2006, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2010, "encyclopedia": "tesamorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1237026", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Massachusetts General Hospital", "Johns Hopkins University", "Hudson Biotech" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tesamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-02-14", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07481734", "url": "https://clinicaltrials.gov/study/NCT07481734", "phase": "Phase 2", "status": "RECRUITING", "title": "Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1237026", "CHEMBL2111290" ], "chembl_names": [ "tesamorelin", "tesamorelin acetate" ] }, { "inn": "teverelix", "key": "teverelix", "chembl": "CHEMBL2103945", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103945/", "stem": "-relix", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103945", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Antev Ltd." ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=teverelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-09", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07457164", "url": "https://clinicaltrials.gov/study/NCT07457164", "phase": "Phase 2", "status": "NOT_YET_RECRUITING", "title": "A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2103945" ], "chembl_names": [ "teverelix" ] }, { "inn": "vipivotide tetraxetan gallium", "key": "vipivotide tetraxetan gallium", "chembl": "CHEMBL4650685", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650685/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650685", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "University of Washington" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vipivotide+tetraxetan+gallium&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-09-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06039371", "url": "https://clinicaltrials.gov/study/NCT06039371", "phase": "Phase 2", "status": "RECRUITING", "title": "Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4650685" ], "chembl_names": [ "vipivotide tetraxetan gallium" ] }, { "inn": "vipivotide tetraxetan gallium ga-68", "key": "vipivotide tetraxetan gallium ga-68", "chembl": "CHEMBL4650357", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650357/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650357", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "University of Washington" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vipivotide+tetraxetan+gallium+ga-68&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-09-01", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06039371", "url": "https://clinicaltrials.gov/study/NCT06039371", "phase": "Phase 2", "status": "RECRUITING", "title": "Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4650357" ], "chembl_names": [ "vipivotide tetraxetan gallium ga-68" ] }, { "inn": "vipivotide tetraxetan lutetium", "key": "vipivotide tetraxetan lutetium", "chembl": "CHEMBL4594730", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594730/", "stem": "-tide; -xetan", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2022, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4594730", "read": "2026-10-01", "active_studies": 8, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "Jonsson Comprehensive Cancer Center", "University of Washington", "Fred Hutchinson Cancer Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vipivotide+tetraxetan+lutetium&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-12-30", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06145633", "url": "https://clinicaltrials.gov/study/NCT06145633", "phase": "Phase 2", "status": "RECRUITING", "title": "Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4594730" ], "chembl_names": [ "vipivotide tetraxetan lutetium" ] }, { "inn": "zelenectide", "key": "zelenectide", "chembl": "CHEMBL5314902", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314902/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314902", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "BicycleTx Limited" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zelenectide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-03", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06225596", "url": "https://clinicaltrials.gov/study/NCT06225596", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314902" ], "chembl_names": [ "zelenectide" ] }, { "inn": "zelenectide pevedotin", "key": "zelenectide pevedotin", "chembl": "CHEMBL5314903", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314903/", "stem": "-dotin; -tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314903", "read": "2026-10-01", "active_studies": 4, "most_advanced_active_phase": "Phase 2", "lead_sponsors": [ "BicycleTx Limited" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zelenectide+pevedotin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-03", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06225596", "url": "https://clinicaltrials.gov/study/NCT06225596", "phase": "Phase 2", "status": "ACTIVE_NOT_RECRUITING", "title": "Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL5314903" ], "chembl_names": [ "zelenectide pevedotin" ] }, { "inn": "balixafortide", "key": "balixafortide", "chembl": "CHEMBL4802129", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802129/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "C-X-C chemokine receptor type 4 antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4802129", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 1", "lead_sponsors": [ "Arsen Osipov" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=balixafortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-02", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06981806", "url": "https://clinicaltrials.gov/study/NCT06981806", "phase": "Phase 1", "status": "NOT_YET_RECRUITING", "title": "Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4802129" ], "chembl_names": [ "balixafortide" ] }, { "inn": "corticorelin", "key": "corticorelin", "chembl": "CHEMBL2108182", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108182/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "corticorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108182", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": "Phase 1", "lead_sponsors": [ "Peter y. Liu", "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=corticorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2022-07-24", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT04037605", "url": "https://clinicaltrials.gov/study/NCT04037605", "phase": "Early phase 1", "status": "ACTIVE_NOT_RECRUITING", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2108182", "CHEMBL2107324" ], "chembl_names": [ "corticorelin", "corticorelin acetate" ] }, { "inn": "peptide t", "key": "peptide t", "chembl": "CHEMBL180971", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL180971/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL180971", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": "Phase 1", "lead_sponsors": [ "Javid Moslehi, MD" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=peptide+t&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2030-11", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07481136", "url": "https://clinicaltrials.gov/study/NCT07481136", "phase": "Phase 1", "status": "NOT_YET_RECRUITING", "title": "64Cu-GRIP B in Patients With Acute Myocarditis", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL180971" ], "chembl_names": [ "peptide t" ] }, { "inn": "abarelix", "key": "abarelix", "chembl": "CHEMBL1252", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1252/", "stem": "-relix", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2003, "encyclopedia": "abarelix", "mechanism": [ "Gonadotropin-releasing hormone receptor antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1252", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=abarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=abarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1252" ], "chembl_names": [ "abarelix" ] }, { "inn": "aclerastide", "key": "aclerastide", "chembl": "CHEMBL4297940", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297940/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297940", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=aclerastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=aclerastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297940" ], "chembl_names": [ "aclerastide" ] }, { "inn": "act-1 peptide", "key": "act-1 peptide", "chembl": "CHEMBL4297964", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297964/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297964", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=act-1+peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=act-1+peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297964" ], "chembl_names": [ "act-1 peptide" ] }, { "inn": "albiglutide", "key": "albiglutide", "chembl": "CHEMBL2107841", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107841/", "stem": "-tide", "usan_year": 2007, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2014, "encyclopedia": "albiglutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107841", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": null, "lead_sponsors": [ "Brigham and Women's Hospital" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=albiglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-05-31", "date_type": "ACTUAL", "state": "primary-completion-reached", "overdue": false, "nct": "NCT05220917", "url": "https://clinicaltrials.gov/study/NCT05220917", "phase": null, "status": "ACTIVE_NOT_RECRUITING", "title": "Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2107841" ], "chembl_names": [ "albiglutide" ] }, { "inn": "albuvirtide", "key": "albuvirtide", "chembl": "CHEMBL4297257", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297257/", "stem": "-tide; -vir-", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "GP41 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297257", "read": "2026-10-01", "active_studies": 2, "most_advanced_active_phase": null, "lead_sponsors": [ "Shanghai Public Health Clinical Center", "Shanxi Bethune Hospital" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=albuvirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2028-07", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07727642", "url": "https://clinicaltrials.gov/study/NCT07727642", "phase": null, "status": "RECRUITING", "title": "Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4297257" ], "chembl_names": [ "albuvirtide" ] }, { "inn": "alizulatide vixocianine", "key": "alizulatide vixocianine", "chembl": "CHEMBL6068041", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068041/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068041", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=alizulatide+vixocianine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=alizulatide+vixocianine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068041" ], "chembl_names": [ "alizulatide vixocianine" ] }, { "inn": "almurtide", "key": "almurtide", "chembl": "CHEMBL3989787", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989787/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989787", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=almurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=almurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989787" ], "chembl_names": [ "almurtide" ] }, { "inn": "alsactide", "key": "alsactide", "chembl": "CHEMBL3989434", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989434/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989434", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=alsactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=alsactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989434" ], "chembl_names": [ "alsactide" ] }, { "inn": "amilomotide", "key": "amilomotide", "chembl": "CHEMBL2108328", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108328/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Amyloid-beta A4 protein vaccine antigen" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108328", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=amilomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=amilomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108328" ], "chembl_names": [ "amilomotide" ] }, { "inn": "amlintide", "key": "amlintide", "chembl": "CHEMBL2109025", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109025/", "stem": "-tide", "usan_year": 1996, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2109025", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": null, "lead_sponsors": [ "University Hospital, Gentofte, Copenhagen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=amlintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07506369", "url": "https://clinicaltrials.gov/study/NCT07506369", "phase": null, "status": "RECRUITING", "title": "Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2109025" ], "chembl_names": [ "amlintide" ] }, { "inn": "anaritide acetate", "key": "anaritide", "chembl": "CHEMBL2108934", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108934/", "stem": "-tide", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108934", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=anaritide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=anaritide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108934" ], "chembl_names": [ "anaritide acetate" ] }, { "inn": "anfibatide", "key": "anfibatide", "chembl": "CHEMBL4297694", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297694/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Platelet glycoprotein Ib alpha chain antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297694", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=anfibatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=anfibatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297694" ], "chembl_names": [ "anfibatide" ] }, { "inn": "argipressin tannate", "key": "argipressin tannate", "chembl": "CHEMBL2108986", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108986/", "stem": "-pressin", "usan_year": 1977, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Vasopressin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108986", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=argipressin+tannate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=argipressin+tannate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108986" ], "chembl_names": [ "argipressin tannate" ] }, { "inn": "argiprestocin", "key": "argiprestocin", "chembl": "CHEMBL2370156", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2370156/", "stem": "-tocin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2370156", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=argiprestocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=argiprestocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2370156" ], "chembl_names": [ "argiprestocin" ] }, { "inn": "aspartocin", "key": "aspartocin", "chembl": "CHEMBL2104384", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104384/", "stem": "-tocin", "usan_year": 1963, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104384", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=aspartocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=aspartocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104384" ], "chembl_names": [ "aspartocin" ] }, { "inn": "avorelin", "key": "avorelin", "chembl": "CHEMBL2103984", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103984/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103984", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=avorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=avorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103984" ], "chembl_names": [ "avorelin" ] }, { "inn": "azetirelin", "key": "azetirelin", "chembl": "CHEMBL2104559", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104559/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104559", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=azetirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=azetirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104559" ], "chembl_names": [ "azetirelin" ] }, { "inn": "baloramotide", "key": "baloramotide", "chembl": "CHEMBL4298083", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298083/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4298083", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=baloramotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=baloramotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4298083" ], "chembl_names": [ "baloramotide" ] }, { "inn": "betiatide", "key": "betiatide", "chembl": "CHEMBL2109104", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109104/", "stem": "-tide", "usan_year": 1990, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2109104", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=betiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=betiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2109104" ], "chembl_names": [ "betiatide" ] }, { "inn": "bevemipretide", "key": "bevemipretide", "chembl": "CHEMBL5314506", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314506/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314506", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=bevemipretide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=bevemipretide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314506" ], "chembl_names": [ "bevemipretide" ] }, { "inn": "bibapcitide", "key": "bibapcitide", "chembl": "CHEMBL2106413", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106413/", "stem": "-tide", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2106413", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=bibapcitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=bibapcitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2106413" ], "chembl_names": [ "bibapcitide" ] }, { "inn": "brimapitide", "key": "brimapitide", "chembl": "CHEMBL4297650", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297650/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "c-Jun N-terminal kinase 3 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297650", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=brimapitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=brimapitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297650" ], "chembl_names": [ "brimapitide" ] }, { "inn": "capromab pendetide", "key": "capromab pendetide", "chembl": "CHEMBL1201579", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201579/", "stem": "-mab; -tide", "usan_year": 1994, "molecule_type": "Antibody", "chembl_max_phase": 4.0, "first_approval": 1996, "encyclopedia": null, "mechanism": [ "Diagnostic agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201579", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=capromab+pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=capromab+pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201579", "CHEMBL2109552", "CHEMBL2108800" ], "chembl_names": [ "capromab pendetide", "yttrium y 90 capromab pendetide", "indium in 111 capromab pendetide" ] }, { "inn": "capromorelin", "key": "capromorelin", "chembl": "CHEMBL113313", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL113313/", "stem": "-relin", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "capromorelin", "mechanism": [ "Ghrelin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL113313", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=capromorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=capromorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL113313" ], "chembl_names": [ "capromorelin" ] }, { "inn": "cargutocin", "key": "cargutocin", "chembl": "CHEMBL2218869", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218869/", "stem": "-tocin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2218869", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cargutocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=cargutocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2218869" ], "chembl_names": [ "cargutocin" ] }, { "inn": "carperitide", "key": "carperitide", "chembl": "CHEMBL2104386", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104386/", "stem": "-tide", "usan_year": 2004, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "carperitide", "mechanism": [ "Atrial natriuretic peptide receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104386", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=carperitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=carperitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104386" ], "chembl_names": [ "carperitide" ] }, { "inn": "cenderitide", "key": "cenderitide", "chembl": "CHEMBL2108721", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108721/", "stem": "-tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108721", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cenderitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=cenderitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108721" ], "chembl_names": [ "cenderitide" ] }, { "inn": "ceruletide", "key": "ceruletide", "chembl": "CHEMBL1201355", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201355/", "stem": "-tide", "usan_year": 1980, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1982, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201355", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ceruletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ceruletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201355" ], "chembl_names": [ "ceruletide" ] }, { "inn": "ceruletide diethylamine", "key": "ceruletide diethylamine", "chembl": "CHEMBL1200755", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200755/", "stem": "-tide", "usan_year": 1980, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1982, "encyclopedia": null, "mechanism": [ "Cholecystokinin A receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1200755", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ceruletide+diethylamine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ceruletide+diethylamine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1200755" ], "chembl_names": [ "ceruletide diethylamine" ] }, { "inn": "cibinetide", "key": "cibinetide", "chembl": "CHEMBL3545305", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545305/", "stem": "-tide", "usan_year": 2015, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "ara-290", "mechanism": [ "Innate repair receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545305", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cibinetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=cibinetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545305" ], "chembl_names": [ "cibinetide" ] }, { "inn": "cilengitide", "key": "cilengitide", "chembl": "CHEMBL429876", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL429876/", "stem": "-tide", "usan_year": 2001, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Integrin alpha-V/beta-3 antagonist", "Integrin alpha-V/beta-5 antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL429876", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cilengitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=cilengitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL429876" ], "chembl_names": [ "cilengitide" ] }, { "inn": "codactide", "key": "codactide", "chembl": "CHEMBL2104378", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104378/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104378", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=codactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=codactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104378" ], "chembl_names": [ "codactide" ] }, { "inn": "copper (64cu) adarulatide tetraxetan", "key": "copper (64cu) adarulatide tetraxetan", "chembl": "CHEMBL6068105", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068105/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068105", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+%2864cu%29+adarulatide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+%2864cu%29+adarulatide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068105" ], "chembl_names": [ "copper (64cu) adarulatide tetraxetan" ] }, { "inn": "copper oxodotreotide", "key": "copper oxodotreotide", "chembl": "CHEMBL4302413", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4302413/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2020, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4302413", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+oxodotreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+oxodotreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4302413" ], "chembl_names": [ "copper oxodotreotide" ] }, { "inn": "copper oxodotreotide cu-64", "key": "copper oxodotreotide cu-64", "chembl": "CHEMBL4297339", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297339/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2020, "encyclopedia": null, "mechanism": [ "Diagnostic agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297339", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+oxodotreotide+cu-64&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=copper+oxodotreotide+cu-64&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297339" ], "chembl_names": [ "copper oxodotreotide cu-64" ] }, { "inn": "corticorelin ovine triflutate", "key": "corticorelin ovine triflutate", "chembl": "CHEMBL1201591", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201591/", "stem": "-relin; -vin-", "usan_year": 1990, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1996, "encyclopedia": "corticorelin", "mechanism": [ "Diagnostic agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201591", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=corticorelin+ovine+triflutate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=corticorelin+ovine+triflutate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201591" ], "chembl_names": [ "corticorelin ovine triflutate" ] }, { "inn": "cotadutide", "key": "cotadutide", "chembl": "CHEMBL4297630", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297630/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "cotadutide", "mechanism": [ "Glucagon receptor agonist", "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297630", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=cotadutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=cotadutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297630" ], "chembl_names": [ "cotadutide" ] }, { "inn": "dalazatide", "key": "dalazatide", "chembl": "CHEMBL4297738", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297738/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297738", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dalazatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dalazatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297738" ], "chembl_names": [ "dalazatide" ] }, { "inn": "danegaptide", "key": "danegaptide", "chembl": "CHEMBL560592", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL560592/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL560592", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=danegaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=danegaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL560592" ], "chembl_names": [ "danegaptide" ] }, { "inn": "davalintide", "key": "davalintide", "chembl": "CHEMBL2105635", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105635/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Calcitonin gene-related peptide type 1 receptor agonist", "Amylin receptor AMY1, CALCR/RAMP1 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105635", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=davalintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=davalintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105635", "CHEMBL2105636" ], "chembl_names": [ "davalintide", "davalintide acetate" ] }, { "inn": "davunetide", "key": "davunetide", "chembl": "CHEMBL2103826", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103826/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "davunetide", "mechanism": [ "Tubulin stabiliser" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103826", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=davunetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=davunetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103826" ], "chembl_names": [ "davunetide" ] }, { "inn": "dazdotuftide", "key": "dazdotuftide", "chembl": "CHEMBL5095261", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095261/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095261", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dazdotuftide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dazdotuftide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095261" ], "chembl_names": [ "dazdotuftide" ] }, { "inn": "delmitide", "key": "delmitide", "chembl": "CHEMBL2108587", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108587/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108587", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=delmitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=delmitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108587" ], "chembl_names": [ "delmitide" ] }, { "inn": "demoxytocin", "key": "demoxytocin", "chembl": "CHEMBL435716", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL435716/", "stem": "-tocin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL435716", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=demoxytocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=demoxytocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL435716" ], "chembl_names": [ "demoxytocin" ] }, { "inn": "depreotide", "key": "depreotide", "chembl": "CHEMBL1908335", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1908335/", "stem": "-tide", "usan_year": 1998, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1999, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1908335", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=depreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=depreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1908335", "CHEMBL5315079", "CHEMBL1201413" ], "chembl_names": [ "depreotide", "depreotide trifluoroacetate", "technetium tc 99m depreotide" ] }, { "inn": "deslorelin", "key": "deslorelin", "chembl": "CHEMBL2365665", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2365665/", "stem": "-relin", "usan_year": 1989, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2365665", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=deslorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=deslorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2365665" ], "chembl_names": [ "deslorelin" ] }, { "inn": "detirelix acetate", "key": "detirelix", "chembl": "CHEMBL2106408", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106408/", "stem": "-relix", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2106408", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=detirelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=detirelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2106408" ], "chembl_names": [ "detirelix acetate" ] }, { "inn": "diamfenetide", "key": "diamfenetide", "chembl": "CHEMBL2104259", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104259/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104259", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=diamfenetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=diamfenetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104259" ], "chembl_names": [ "diamfenetide" ] }, { "inn": "diclometide", "key": "diclometide", "chembl": "CHEMBL2106106", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106106/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2106106", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=diclometide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=diclometide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2106106" ], "chembl_names": [ "diclometide" ] }, { "inn": "dirucotide", "key": "dirucotide", "chembl": "CHEMBL2105639", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105639/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105639", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dirucotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dirucotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105639" ], "chembl_names": [ "dirucotide" ] }, { "inn": "disaccharide tripeptide glycerol dipalmitoyl", "key": "disaccharide tripeptide glycerol dipalmitoyl", "chembl": "CHEMBL4297391", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297391/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297391", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=disaccharide+tripeptide+glycerol+dipalmitoyl&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=disaccharide+tripeptide+glycerol+dipalmitoyl&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297391" ], "chembl_names": [ "disaccharide tripeptide glycerol dipalmitoyl" ] }, { "inn": "disitertide", "key": "disitertide", "chembl": "CHEMBL2108346", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108346/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108346", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=disitertide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=disitertide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108346" ], "chembl_names": [ "disitertide" ] }, { "inn": "disomotide", "key": "disomotide", "chembl": "CHEMBL263429", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL263429/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL263429", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=disomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=disomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL263429" ], "chembl_names": [ "disomotide" ] }, { "inn": "dolcanatide", "key": "dolcanatide", "chembl": "CHEMBL3545122", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545122/", "stem": "-tide", "usan_year": 2015, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Heat-stable enterotoxin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545122", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dolcanatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dolcanatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545122" ], "chembl_names": [ "dolcanatide" ] }, { "inn": "doreptide", "key": "doreptide", "chembl": "CHEMBL2109123", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109123/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2109123", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=doreptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=doreptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2109123" ], "chembl_names": [ "doreptide" ] }, { "inn": "dumorelin", "key": "dumorelin", "chembl": "CHEMBL2108374", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108374/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108374", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dumorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dumorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108374" ], "chembl_names": [ "dumorelin" ] }, { "inn": "dusquetide", "key": "dusquetide", "chembl": "CHEMBL3545314", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545314/", "stem": "-tide", "usan_year": 2014, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545314", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=dusquetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=dusquetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545314" ], "chembl_names": [ "dusquetide" ] }, { "inn": "ebiratide", "key": "ebiratide", "chembl": "CHEMBL2106396", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106396/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2106396", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ebiratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ebiratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2106396" ], "chembl_names": [ "ebiratide" ] }, { "inn": "ecallantide", "key": "ecallantide", "chembl": "CHEMBL1201837", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201837/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2009, "encyclopedia": null, "mechanism": [ "Plasma kallikrein inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201837", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ecallantide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ecallantide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201837" ], "chembl_names": [ "ecallantide" ] }, { "inn": "ederimotide", "key": "ederimotide", "chembl": "CHEMBL5314734", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314734/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314734", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ederimotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ederimotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314734" ], "chembl_names": [ "ederimotide" ] }, { "inn": "edotreotide gallium ga-68", "key": "edotreotide gallium ga-68", "chembl": "CHEMBL4297340", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297340/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2016, "encyclopedia": null, "mechanism": [ "Diagnostic agent", "Diagnostic" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297340", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+gallium+ga-68&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+gallium+ga-68&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297340" ], "chembl_names": [ "edotreotide gallium ga-68" ] }, { "inn": "edotreotide yttrium", "key": "edotreotide yttrium", "chembl": "CHEMBL386768", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL386768/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL386768", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+yttrium&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+yttrium&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL386768" ], "chembl_names": [ "edotreotide yttrium" ] }, { "inn": "edotreotide yttrium y-90", "key": "edotreotide yttrium y-90", "chembl": "CHEMBL4297342", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297342/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297342", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+yttrium+y-90&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=edotreotide+yttrium+y-90&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297342" ], "chembl_names": [ "edotreotide yttrium y-90" ] }, { "inn": "edratide", "key": "edratide", "chembl": "CHEMBL2107743", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107743/", "stem": "-tide", "usan_year": 2004, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107743", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=edratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=edratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107743" ], "chembl_names": [ "edratide" ] }, { "inn": "efinopegdutide", "key": "efinopegdutide", "chembl": "CHEMBL4297576", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297576/", "stem": "ef-; -peg-; -tide", "usan_year": 2019, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Glucagon-like peptide 1 receptor agonist", "Glucagon receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297576", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=efinopegdutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=efinopegdutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297576" ], "chembl_names": [ "efinopegdutide" ] }, { "inn": "efmedaglutide alfa", "key": "efmedaglutide alfa", "chembl": "CHEMBL6068240", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068240/", "stem": "ef-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068240", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=efmedaglutide+alfa&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=efmedaglutide+alfa&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068240" ], "chembl_names": [ "efmedaglutide alfa" ] }, { "inn": "efocipegtrutide", "key": "efocipegtrutide", "chembl": "CHEMBL5095149", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095149/", "stem": "ef-; -peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095149", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=efocipegtrutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=efocipegtrutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095149" ], "chembl_names": [ "efocipegtrutide" ] }, { "inn": "efpeglenatide", "key": "efpeglenatide", "chembl": "CHEMBL4650470", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650470/", "stem": "ef-; -peg-; -tide", "usan_year": 2020, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "efpeglenatide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650470", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=efpeglenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=efpeglenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4650470" ], "chembl_names": [ "efpeglenatide" ] }, { "inn": "elpamotide", "key": "elpamotide", "chembl": "CHEMBL2108295", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108295/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108295", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=elpamotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=elpamotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108295" ], "chembl_names": [ "elpamotide" ] }, { "inn": "elsiglutide", "key": "elsiglutide", "chembl": "CHEMBL2108318", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108318/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "elsiglutide", "mechanism": [ "Glucagon-like peptide 2 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108318", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=elsiglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=elsiglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108318" ], "chembl_names": [ "elsiglutide" ] }, { "inn": "emideltide", "key": "emideltide", "chembl": "CHEMBL2104403", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104403/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104403", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=emideltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=emideltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104403" ], "chembl_names": [ "emideltide" ] }, { "inn": "enavermotide", "key": "enavermotide", "chembl": "CHEMBL5314828", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314828/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314828", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=enavermotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=enavermotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314828" ], "chembl_names": [ "enavermotide" ] }, { "inn": "enfuvirtide", "key": "enfuvirtide", "chembl": "CHEMBL525076", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL525076/", "stem": "-tide; -vir-", "usan_year": 2001, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2003, "encyclopedia": null, "mechanism": [ "Transmembrane glycoprotein gp41 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL525076", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=enfuvirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=enfuvirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL525076" ], "chembl_names": [ "enfuvirtide" ] }, { "inn": "enlicitide chloride", "key": "enlicitide chloride", "chembl": "CHEMBL6067978", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6067978/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6067978", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=enlicitide+chloride&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=enlicitide+chloride&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6067978" ], "chembl_names": [ "enlicitide chloride" ] }, { "inn": "ensereptide", "key": "ensereptide", "chembl": "CHEMBL5095372", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095372/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095372", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ensereptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ensereptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095372" ], "chembl_names": [ "ensereptide" ] }, { "inn": "etarfolatide", "key": "etarfolatide", "chembl": "CHEMBL4297280", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297280/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297280", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=etarfolatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=etarfolatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297280", "CHEMBL3707391" ], "chembl_names": [ "etarfolatide", "technetium (99mtc) etarfolatide" ] }, { "inn": "etimumotide", "key": "etimumotide", "chembl": "CHEMBL5314741", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314741/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314741", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=etimumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=etimumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314741" ], "chembl_names": [ "etimumotide" ] }, { "inn": "examorelin", "key": "examorelin", "chembl": "CHEMBL108335", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL108335/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "hexarelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL108335", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=examorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=examorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL108335" ], "chembl_names": [ "examorelin" ] }, { "inn": "felypressin", "key": "felypressin", "chembl": "CHEMBL3185126", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3185126/", "stem": "-pressin", "usan_year": 1965, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "felypressin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3185126", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=felypressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=felypressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3185126" ], "chembl_names": [ "felypressin" ] }, { "inn": "fequesetide", "key": "fequesetide", "chembl": "CHEMBL5314679", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314679/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314679", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fequesetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fequesetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314679" ], "chembl_names": [ "fequesetide" ] }, { "inn": "fertirelin", "key": "fertirelin", "chembl": "CHEMBL3272563", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3272563/", "stem": "-relin", "usan_year": 1988, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3272563", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fertirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fertirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3272563" ], "chembl_names": [ "fertirelin" ] }, { "inn": "fexapotide", "key": "fexapotide", "chembl": "CHEMBL3545061", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545061/", "stem": "-tide", "usan_year": 2015, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545061", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fexapotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fexapotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545061" ], "chembl_names": [ "fexapotide" ] }, { "inn": "fexapotide triflutate", "key": "fexapotide triflutate", "chembl": "CHEMBL3707309", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707309/", "stem": "-tide", "usan_year": 2015, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3707309", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fexapotide+triflutate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fexapotide+triflutate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3707309" ], "chembl_names": [ "fexapotide triflutate" ] }, { "inn": "fluciclatide", "key": "fluciclatide", "chembl": "CHEMBL3990277", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990277/", "stem": "-tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3990277", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fluciclatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fluciclatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3990277" ], "chembl_names": [ "fluciclatide" ] }, { "inn": "fluciclatide f 18", "key": "fluciclatide f 18", "chembl": "CHEMBL3989518", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989518/", "stem": "-tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989518", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=fluciclatide+f+18&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=fluciclatide+f+18&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989518" ], "chembl_names": [ "fluciclatide f 18" ] }, { "inn": "froniglutide", "key": "froniglutide", "chembl": "CHEMBL5314983", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314983/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314983", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=froniglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=froniglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314983" ], "chembl_names": [ "froniglutide" ] }, { "inn": "gallium (68ga) rofapitide tetraxetan", "key": "gallium (68ga) rofapitide tetraxetan", "chembl": "CHEMBL5314464", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314464/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314464", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gallium+%2868ga%29+rofapitide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=gallium+%2868ga%29+rofapitide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314464" ], "chembl_names": [ "gallium (68ga) rofapitide tetraxetan" ] }, { "inn": "gallium rofapitidexetan", "key": "gallium rofapitidexetan", "chembl": "CHEMBL5316152", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5316152/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5316152", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gallium+rofapitidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=gallium+rofapitidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5316152" ], "chembl_names": [ "gallium rofapitidexetan" ] }, { "inn": "ganipatide", "key": "ganipatide", "chembl": "CHEMBL5314835", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314835/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314835", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ganipatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ganipatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314835" ], "chembl_names": [ "ganipatide" ] }, { "inn": "gersizangitide", "key": "gersizangitide", "chembl": "CHEMBL5095123", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095123/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095123", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gersizangitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=gersizangitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095123" ], "chembl_names": [ "gersizangitide" ] }, { "inn": "giractide", "key": "giractide", "chembl": "CHEMBL2370090", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2370090/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2370090", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=giractide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=giractide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2370090" ], "chembl_names": [ "giractide" ] }, { "inn": "glisentide", "key": "glisentide", "chembl": "CHEMBL2105089", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105089/", "stem": "gli-; -tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105089", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=glisentide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=glisentide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105089" ], "chembl_names": [ "glisentide" ] }, { "inn": "glucagon-like peptide ii", "key": "glucagon-like peptide ii", "chembl": "CHEMBL4297958", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297958/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297958", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=glucagon-like+peptide+ii&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=glucagon-like+peptide+ii&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297958" ], "chembl_names": [ "glucagon-like peptide ii" ] }, { "inn": "goralatide", "key": "goralatide", "chembl": "CHEMBL420741", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL420741/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL420741", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=goralatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=goralatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL420741" ], "chembl_names": [ "goralatide" ] }, { "inn": "gozetotide alf-18", "key": "gozetotide alf-18", "chembl": "CHEMBL4650355", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650355/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650355", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=gozetotide+alf-18&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=gozetotide+alf-18&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4650355" ], "chembl_names": [ "gozetotide alf-18" ] }, { "inn": "human c-peptide", "key": "human c-peptide", "chembl": "CHEMBL4594409", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594409/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4594409", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=human+c-peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=human+c-peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4594409" ], "chembl_names": [ "human c-peptide" ] }, { "inn": "icrocaptide", "key": "icrocaptide", "chembl": "CHEMBL2107753", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107753/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107753", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=icrocaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=icrocaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107753" ], "chembl_names": [ "icrocaptide" ] }, { "inn": "ilatreotide", "key": "ilatreotide", "chembl": "CHEMBL2104390", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104390/", "stem": "-tide", "usan_year": null, "molecule_type": "Oligosaccharide", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2104390", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ilatreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ilatreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2104390" ], "chembl_names": [ "ilatreotide" ] }, { "inn": "imsamotide", "key": "imsamotide", "chembl": "CHEMBL5314745", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314745/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314745", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=imsamotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=imsamotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314745" ], "chembl_names": [ "imsamotide" ] }, { "inn": "indium in 111 satumomab pendetide", "key": "satumomab pendetide", "chembl": "CHEMBL1743091", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743091/", "stem": "-mab; -tide", "usan_year": 1993, "molecule_type": "Antibody", "chembl_max_phase": 4.0, "first_approval": 1991, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1743091", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=satumomab+pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=satumomab+pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1743091" ], "chembl_names": [ "indium in 111 satumomab pendetide" ] }, { "inn": "indium pentetreotide", "key": "indium pentetreotide", "chembl": "CHEMBL2110556", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110556/", "stem": "-tide", "usan_year": 1995, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1994, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2110556", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=indium+pentetreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=indium+pentetreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2110556" ], "chembl_names": [ "indium pentetreotide" ] }, { "inn": "invopressin", "key": "invopressin", "chembl": "CHEMBL5314925", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314925/", "stem": "-pressin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314925", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=invopressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=invopressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314925" ], "chembl_names": [ "invopressin" ] }, { "inn": "iodine i124 evuzamitide", "key": "iodine i124 evuzamitide", "chembl": "CHEMBL5314633", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314633/", "stem": "io-; -tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314633", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=iodine+i124+evuzamitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=iodine+i124+evuzamitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314633" ], "chembl_names": [ "iodine i124 evuzamitide" ] }, { "inn": "ipamorelin", "key": "ipamorelin", "chembl": "CHEMBL58547", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL58547/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "ipamorelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL58547", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ipamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ipamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL58547" ], "chembl_names": [ "ipamorelin" ] }, { "inn": "irucalantide", "key": "irucalantide", "chembl": "CHEMBL5314840", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314840/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314840", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=irucalantide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=irucalantide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314840" ], "chembl_names": [ "irucalantide" ] }, { "inn": "iturelix", "key": "iturelix", "chembl": "CHEMBL3989438", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989438/", "stem": "-relix", "usan_year": 2000, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989438", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=iturelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=iturelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989438" ], "chembl_names": [ "iturelix" ] }, { "inn": "lagatide", "key": "lagatide", "chembl": "CHEMBL2218863", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218863/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2218863", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lagatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lagatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2218863" ], "chembl_names": [ "lagatide" ] }, { "inn": "lancovutide", "key": "lancovutide", "chembl": "CHEMBL2108327", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108327/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108327", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lancovutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lancovutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108327" ], "chembl_names": [ "lancovutide" ] }, { "inn": "larazotide", "key": "larazotide", "chembl": "CHEMBL2105646", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105646/", "stem": "-tide", "usan_year": 2007, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "larazotide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105646", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=larazotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=larazotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105646", "CHEMBL2103815" ], "chembl_names": [ "larazotide", "larazotide acetate" ] }, { "inn": "lead (212pb) bamzireotide navoxetan", "key": "lead (212pb) bamzireotide navoxetan", "chembl": "CHEMBL6068067", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068067/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068067", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+%28212pb%29+bamzireotide+navoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+%28212pb%29+bamzireotide+navoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068067" ], "chembl_names": [ "lead (212pb) bamzireotide navoxetan" ] }, { "inn": "lead (212pb) lapemelanotide zapixetan", "key": "lead (212pb) lapemelanotide zapixetan", "chembl": "CHEMBL6068068", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068068/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068068", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+%28212pb%29+lapemelanotide+zapixetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+%28212pb%29+lapemelanotide+zapixetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068068" ], "chembl_names": [ "lead (212pb) lapemelanotide zapixetan" ] }, { "inn": "lead bamzireotide navoxetan", "key": "lead bamzireotide navoxetan", "chembl": "CHEMBL6068769", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068769/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068769", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+bamzireotide+navoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+bamzireotide+navoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068769" ], "chembl_names": [ "lead bamzireotide navoxetan" ] }, { "inn": "lead lapemelanotide zapixetan", "key": "lead lapemelanotide zapixetan", "chembl": "CHEMBL6068770", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068770/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068770", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+lapemelanotide+zapixetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lead+lapemelanotide+zapixetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068770" ], "chembl_names": [ "lead lapemelanotide zapixetan" ] }, { "inn": "leconotide", "key": "leconotide", "chembl": "CHEMBL2108419", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108419/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108419", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=leconotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=leconotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108419" ], "chembl_names": [ "leconotide" ] }, { "inn": "lenomorelin", "key": "lenomorelin", "chembl": "CHEMBL2108303", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108303/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "ghrelin", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108303", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lenomorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lenomorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108303" ], "chembl_names": [ "lenomorelin" ] }, { "inn": "livoletide", "key": "livoletide", "chembl": "CHEMBL2029605", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2029605/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2029605", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=livoletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=livoletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2029605" ], "chembl_names": [ "livoletide" ] }, { "inn": "lorutengitide", "key": "lorutengitide", "chembl": "CHEMBL6068133", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068133/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068133", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lorutengitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lorutengitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068133" ], "chembl_names": [ "lorutengitide" ] }, { "inn": "lucicebtide", "key": "lucicebtide", "chembl": "CHEMBL5314846", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314846/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314846", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lucicebtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lucicebtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314846" ], "chembl_names": [ "lucicebtide" ] }, { "inn": "lusupultide", "key": "lusupultide", "chembl": "CHEMBL2218909", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218909/", "stem": "-tide", "usan_year": 2007, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2218909", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lusupultide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lusupultide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2218909" ], "chembl_names": [ "lusupultide" ] }, { "inn": "lutetium (177lu) tezuvotide tetraxetan", "key": "lutetium (177lu) tezuvotide tetraxetan", "chembl": "CHEMBL6068058", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068058/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068058", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+%28177lu%29+tezuvotide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+%28177lu%29+tezuvotide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068058" ], "chembl_names": [ "lutetium (177lu) tezuvotide tetraxetan" ] }, { "inn": "lutetium (lu177) rofapitide tetraxetan", "key": "lutetium (lu177) rofapitide tetraxetan", "chembl": "CHEMBL5314468", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314468/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314468", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+%28lu177%29+rofapitide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+%28lu177%29+rofapitide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314468" ], "chembl_names": [ "lutetium (lu177) rofapitide tetraxetan" ] }, { "inn": "lutetium rofapitidexetan", "key": "lutetium rofapitidexetan", "chembl": "CHEMBL5316153", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5316153/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5316153", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+rofapitidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+rofapitidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5316153" ], "chembl_names": [ "lutetium rofapitidexetan" ] }, { "inn": "lutetium tezuvotidexetan", "key": "lutetium tezuvotidexetan", "chembl": "CHEMBL6068768", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068768/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068768", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+tezuvotidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutetium+tezuvotidexetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068768" ], "chembl_names": [ "lutetium tezuvotidexetan" ] }, { "inn": "lutrelin", "key": "lutrelin", "chembl": "CHEMBL2370578", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2370578/", "stem": "-relin", "usan_year": 1984, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2370578", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutrelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=lutrelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2370578" ], "chembl_names": [ "lutrelin" ] }, { "inn": "lypressin", "key": "lypressin", "chembl": "CHEMBL1200690", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200690/", "stem": "-pressin", "usan_year": 1965, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1982, "encyclopedia": null, "mechanism": [ "Vasopressin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1200690", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": null, "lead_sponsors": [ "Wael Elbanna Clinic" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=lypressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2024-06-30", "date_type": "ESTIMATED", "state": "estimate-lapsed", "overdue": true, "nct": "NCT05266534", "url": "https://clinicaltrials.gov/study/NCT05266534", "phase": null, "status": "RECRUITING", "title": "The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL1200690" ], "chembl_names": [ "lypressin" ] }, { "inn": "macimorelin", "key": "macimorelin", "chembl": "CHEMBL278623", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL278623/", "stem": "-relin", "usan_year": 2013, "molecule_type": "Small molecule", "chembl_max_phase": 4.0, "first_approval": 2017, "encyclopedia": "macimorelin", "mechanism": [ "Ghrelin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL278623", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=macimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=macimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL278623", "CHEMBL2364617" ], "chembl_names": [ "macimorelin", "macimorelin acetate" ] }, { "inn": "maraciclatide", "key": "maraciclatide", "chembl": "CHEMBL3989765", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989765/", "stem": "-tide", "usan_year": 2009, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989765", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=maraciclatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=maraciclatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989765" ], "chembl_names": [ "maraciclatide" ] }, { "inn": "marlumotide", "key": "marlumotide", "chembl": "CHEMBL5314752", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314752/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314752", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=marlumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=marlumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314752" ], "chembl_names": [ "marlumotide" ] }, { "inn": "mertiatide", "key": "mertiatide", "chembl": "CHEMBL1615778", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1615778/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1990, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1615778", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mertiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=mertiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1615778", "CHEMBL2107488" ], "chembl_names": [ "mertiatide", "technetium tc 99m mertiatide" ] }, { "inn": "mibenratide", "key": "mibenratide", "chembl": "CHEMBL4297617", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297617/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Unknown" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297617", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mibenratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=mibenratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297617" ], "chembl_names": [ "mibenratide" ] }, { "inn": "mifamurtide acid", "key": "mifamurtide acid", "chembl": "CHEMBL2111100", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111100/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Small molecule", "chembl_max_phase": 4.0, "first_approval": 2009, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2111100", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=mifamurtide+acid&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=mifamurtide+acid&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2111100" ], "chembl_names": [ "mifamurtide acid" ] }, { "inn": "milpocitide", "key": "milpocitide", "chembl": "CHEMBL5314692", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314692/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314692", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=milpocitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=milpocitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314692" ], "chembl_names": [ "milpocitide" ] }, { "inn": "modimelanotide", "key": "modimelanotide", "chembl": "CHEMBL3545104", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545104/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Melanocortin receptor 3 agonist", "Melanocortin receptor 1 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545104", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=modimelanotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=modimelanotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545104" ], "chembl_names": [ "modimelanotide" ] }, { "inn": "montirelin", "key": "montirelin", "chembl": "CHEMBL2304039", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2304039/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2304039", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=montirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=montirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2304039" ], "chembl_names": [ "montirelin" ] }, { "inn": "murabutide", "key": "murabutide", "chembl": "CHEMBL1908312", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1908312/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1908312", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=murabutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=murabutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1908312" ], "chembl_names": [ "murabutide" ] }, { "inn": "nacartocin", "key": "nacartocin", "chembl": "CHEMBL2218901", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2218901/", "stem": "-tocin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2218901", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nacartocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=nacartocin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2218901" ], "chembl_names": [ "nacartocin" ] }, { "inn": "nemifitide", "key": "nemifitide", "chembl": "CHEMBL2107761", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107761/", "stem": "-tide", "usan_year": 2002, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107761", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nemifitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=nemifitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107761" ], "chembl_names": [ "nemifitide" ] }, { "inn": "nerinetide", "key": "nerinetide", "chembl": "CHEMBL502630", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502630/", "stem": "-tide", "usan_year": 2019, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL502630", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nerinetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=nerinetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL502630" ], "chembl_names": [ "nerinetide" ] }, { "inn": "nisotirostide", "key": "nisotirostide", "chembl": "CHEMBL5315028", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5315028/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5315028", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nisotirostide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=nisotirostide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5315028" ], "chembl_names": [ "nisotirostide" ] }, { "inn": "noraramtide", "key": "noraramtide", "chembl": "CHEMBL6068397", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068397/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068397", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=noraramtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=noraramtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068397" ], "chembl_names": [ "noraramtide" ] }, { "inn": "norleusactide", "key": "norleusactide", "chembl": "CHEMBL2103941", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103941/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103941", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=norleusactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=norleusactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103941" ], "chembl_names": [ "norleusactide" ] }, { "inn": "nosiheptide", "key": "nosiheptide", "chembl": "CHEMBL2103750", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103750/", "stem": "-tide", "usan_year": 1978, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103750", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=nosiheptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=nosiheptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103750" ], "chembl_names": [ "nosiheptide" ] }, { "inn": "obinepitide", "key": "obinepitide", "chembl": "CHEMBL2108338", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108338/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108338", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=obinepitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=obinepitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108338" ], "chembl_names": [ "obinepitide" ] }, { "inn": "ociltide", "key": "ociltide", "chembl": "CHEMBL4297081", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297081/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297081", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ociltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ociltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297081" ], "chembl_names": [ "ociltide" ] }, { "inn": "omramotide", "key": "omramotide", "chembl": "CHEMBL5314855", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314855/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314855", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=omramotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=omramotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314855" ], "chembl_names": [ "omramotide" ] }, { "inn": "onvitrelin ucalontide", "key": "onvitrelin ucalontide", "chembl": "CHEMBL4297748", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297748/", "stem": "-relin; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Cell membrane disrupting agent", "Gonadotropin-releasing hormone receptor binding agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297748", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=onvitrelin+ucalontide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=onvitrelin+ucalontide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297748" ], "chembl_names": [ "onvitrelin ucalontide" ] }, { "inn": "ornipressin", "key": "ornipressin", "chembl": "CHEMBL1819440", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1819440/", "stem": "-pressin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1819440", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ornipressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ornipressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1819440" ], "chembl_names": [ "ornipressin" ] }, { "inn": "orotirelin", "key": "orotirelin", "chembl": "CHEMBL2105278", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105278/", "stem": "-relin", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105278", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=orotirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=orotirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105278" ], "chembl_names": [ "orotirelin" ] }, { "inn": "ovemotide", "key": "ovemotide", "chembl": "CHEMBL263441", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL263441/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL263441", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ovemotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ovemotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL263441" ], "chembl_names": [ "ovemotide" ] }, { "inn": "oximbomotide", "key": "oximbomotide", "chembl": "CHEMBL5314861", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314861/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314861", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=oximbomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=oximbomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314861" ], "chembl_names": [ "oximbomotide" ] }, { "inn": "ozarelix", "key": "ozarelix", "chembl": "CHEMBL2108312", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108312/", "stem": "-relix", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Gonadotropin-releasing hormone receptor antagonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108312", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ozarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ozarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108312" ], "chembl_names": [ "ozarelix" ] }, { "inn": "paluratide", "key": "paluratide", "chembl": "CHEMBL6068161", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068161/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068161", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=paluratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=paluratide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068161" ], "chembl_names": [ "paluratide" ] }, { "inn": "pancreatic polypeptide", "key": "pancreatic polypeptide", "chembl": "CHEMBL4540843", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4540843/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4540843", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": null, "lead_sponsors": [ "University Hospital, Gentofte, Copenhagen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pancreatic+polypeptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07506369", "url": "https://clinicaltrials.gov/study/NCT07506369", "phase": null, "status": "RECRUITING", "title": "Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4540843" ], "chembl_names": [ "pancreatic polypeptide" ] }, { "inn": "pareptide", "key": "pareptide", "chembl": "CHEMBL2111011", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111011/", "stem": "-tide", "usan_year": 1977, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2111011", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pareptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pareptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2111011" ], "chembl_names": [ "pareptide" ] }, { "inn": "peforelin", "key": "peforelin", "chembl": "CHEMBL2108043", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108043/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108043", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=peforelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=peforelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108043" ], "chembl_names": [ "peforelin" ] }, { "inn": "pegapamodutide", "key": "pegapamodutide", "chembl": "CHEMBL3990012", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990012/", "stem": "peg-; -tide", "usan_year": 2016, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3990012", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegapamodutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegapamodutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3990012" ], "chembl_names": [ "pegapamodutide" ] }, { "inn": "peginesatide", "key": "peginesatide", "chembl": "CHEMBL2107866", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107866/", "stem": "peg-; -tide", "usan_year": 2010, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2012, "encyclopedia": null, "mechanism": [ "Erythropoietin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107866", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=peginesatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=peginesatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107866", "CHEMBL1963684" ], "chembl_names": [ "peginesatide", "peginesatide acetate" ] }, { "inn": "pegloprastide", "key": "pegloprastide", "chembl": "CHEMBL5095310", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095310/", "stem": "peg-; -tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095310", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegloprastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegloprastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095310" ], "chembl_names": [ "pegloprastide" ] }, { "inn": "pegmispotide", "key": "pegmispotide", "chembl": "CHEMBL5314863", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314863/", "stem": "peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314863", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegmispotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegmispotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314863" ], "chembl_names": [ "pegmispotide" ] }, { "inn": "pegsebrenatide", "key": "pegsebrenatide", "chembl": "CHEMBL4650495", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650495/", "stem": "peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4650495", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegsebrenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pegsebrenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4650495" ], "chembl_names": [ "pegsebrenatide" ] }, { "inn": "pendetide", "key": "pendetide", "chembl": "CHEMBL2108754", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108754/", "stem": "-tide", "usan_year": null, "molecule_type": "Unknown", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108754", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pendetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108754" ], "chembl_names": [ "pendetide" ] }, { "inn": "pentetreotide", "key": "pentetreotide", "chembl": "CHEMBL2108757", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108757/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1994, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108757", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pentetreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pentetreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108757", "CHEMBL1200642" ], "chembl_names": [ "pentetreotide", "indium in 111 pentetreotide" ] }, { "inn": "pentigetide", "key": "pentigetide", "chembl": "CHEMBL2304033", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2304033/", "stem": "-tide", "usan_year": 1988, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2304033", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pentigetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pentigetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2304033" ], "chembl_names": [ "pentigetide" ] }, { "inn": "peptide yy human (3-36)", "key": "peptide yy human (3-36)", "chembl": "CHEMBL4297971", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297971/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Neuropeptide Y receptor type 2 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297971", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=peptide+yy+human+%283-36%29&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=peptide+yy+human+%283-36%29&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297971" ], "chembl_names": [ "peptide yy human (3-36)" ] }, { "inn": "pezadeftide", "key": "pezadeftide", "chembl": "CHEMBL5095144", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095144/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095144", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pezadeftide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pezadeftide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095144" ], "chembl_names": [ "pezadeftide" ] }, { "inn": "pimelautide", "key": "pimelautide", "chembl": "CHEMBL3989437", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989437/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989437", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pimelautide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pimelautide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989437" ], "chembl_names": [ "pimelautide" ] }, { "inn": "pobrolitide", "key": "pobrolitide", "chembl": "CHEMBL5314865", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314865/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314865", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pobrolitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pobrolitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314865" ], "chembl_names": [ "pobrolitide" ] }, { "inn": "posatirelin", "key": "posatirelin", "chembl": "CHEMBL2105243", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105243/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105243", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=posatirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=posatirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105243" ], "chembl_names": [ "posatirelin" ] }, { "inn": "pr1 leukemia peptide vaccine", "key": "pr1 leukemia peptide vaccine", "chembl": "CHEMBL4297811", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297811/", "stem": "-tide", "usan_year": null, "molecule_type": "Vaccine component", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297811", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pr1+leukemia+peptide+vaccine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pr1+leukemia+peptide+vaccine&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297811" ], "chembl_names": [ "pr1 leukemia peptide vaccine" ] }, { "inn": "pralmorelin", "key": "pralmorelin", "chembl": "CHEMBL106593", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL106593/", "stem": "-relin", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "ghrp-2", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL106593", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pralmorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=pralmorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL106593" ], "chembl_names": [ "pralmorelin" ] }, { "inn": "pramlintide", "key": "pramlintide", "chembl": "CHEMBL2103758", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103758/", "stem": "-tide", "usan_year": 1996, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2005, "encyclopedia": "pramlintide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103758", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": "Early phase 1", "lead_sponsors": [ "Boston University", "University Hospital, Gentofte, Copenhagen", "University of Copenhagen" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=pramlintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2026-10", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT07506369", "url": "https://clinicaltrials.gov/study/NCT07506369", "phase": null, "status": "RECRUITING", "title": "Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL2103758", "CHEMBL3833353" ], "chembl_names": [ "pramlintide", "pramlintide acetate" ] }, { "inn": "prazarelix", "key": "prazarelix", "chembl": "CHEMBL409018", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL409018/", "stem": "-relix", "usan_year": 1998, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL409018", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=prazarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=prazarelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL409018" ], "chembl_names": [ "prazarelix" ] }, { "inn": "protirelin", "key": "protirelin", "chembl": "CHEMBL1472", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1472/", "stem": "-relin", "usan_year": 1974, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1976, "encyclopedia": "protirelin", "mechanism": [ "Thyrotropin-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1472", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=protirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=protirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1472" ], "chembl_names": [ "protirelin" ] }, { "inn": "quazomotide", "key": "quazomotide", "chembl": "CHEMBL5314767", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314767/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314767", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=quazomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=quazomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314767" ], "chembl_names": [ "quazomotide" ] }, { "inn": "ramorelix", "key": "ramorelix", "chembl": "CHEMBL3989808", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989808/", "stem": "-relix", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989808", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ramorelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ramorelix&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989808" ], "chembl_names": [ "ramorelix" ] }, { "inn": "recanaclotide", "key": "recanaclotide", "chembl": "CHEMBL3707244", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707244/", "stem": "-tide", "usan_year": 2015, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3707244", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=recanaclotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=recanaclotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3707244" ], "chembl_names": [ "recanaclotide" ] }, { "inn": "redasemtide", "key": "redasemtide", "chembl": "CHEMBL6068588", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068588/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068588", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=redasemtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=redasemtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068588" ], "chembl_names": [ "redasemtide" ] }, { "inn": "relamorelin", "key": "relamorelin", "chembl": "CHEMBL4297525", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297525/", "stem": "-relin", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "relamorelin", "mechanism": [ "Ghrelin receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297525", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=relamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=relamorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297525" ], "chembl_names": [ "relamorelin" ] }, { "inn": "rimtoregtide", "key": "rimtoregtide", "chembl": "CHEMBL5095151", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095151/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095151", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rimtoregtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rimtoregtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095151" ], "chembl_names": [ "rimtoregtide" ] }, { "inn": "rismorelin", "key": "rismorelin", "chembl": "CHEMBL2108294", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108294/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108294", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rismorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rismorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108294" ], "chembl_names": [ "rismorelin" ] }, { "inn": "rolipoltide", "key": "rolipoltide", "chembl": "CHEMBL2108284", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108284/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108284", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rolipoltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rolipoltide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108284" ], "chembl_names": [ "rolipoltide" ] }, { "inn": "romurtide", "key": "romurtide", "chembl": "CHEMBL1908331", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1908331/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1908331", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=romurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=romurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1908331" ], "chembl_names": [ "romurtide" ] }, { "inn": "rotigaptide", "key": "rotigaptide", "chembl": "CHEMBL450656", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL450656/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL450656", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rotigaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rotigaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL450656" ], "chembl_names": [ "rotigaptide" ] }, { "inn": "rovatirelin", "key": "rovatirelin", "chembl": "CHEMBL4297622", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297622/", "stem": "-relin", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Thyrotropin-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297622", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rovatirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rovatirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297622" ], "chembl_names": [ "rovatirelin" ] }, { "inn": "rusalatide", "key": "rusalatide", "chembl": "CHEMBL2111105", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111105/", "stem": "-sal-; -tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2111105", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=rusalatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=rusalatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2111105", "CHEMBL2107369" ], "chembl_names": [ "rusalatide", "rusalatide acetate" ] }, { "inn": "ruxotemitide", "key": "ruxotemitide", "chembl": "CHEMBL4297628", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297628/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297628", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ruxotemitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ruxotemitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297628" ], "chembl_names": [ "ruxotemitide" ] }, { "inn": "satoreotide tetraxetan", "key": "satoreotide tetraxetan", "chembl": "CHEMBL4297531", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297531/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297531", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=satoreotide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=satoreotide+tetraxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297531" ], "chembl_names": [ "satoreotide tetraxetan" ] }, { "inn": "satoreotide trizoxetan", "key": "satoreotide trizoxetan", "chembl": "CHEMBL4297532", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297532/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297532", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=satoreotide+trizoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=satoreotide+trizoxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297532" ], "chembl_names": [ "satoreotide trizoxetan" ] }, { "inn": "seglitide", "key": "seglitide", "chembl": "CHEMBL311695", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL311695/", "stem": "-tide", "usan_year": 1987, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL311695", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=seglitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=seglitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL311695" ], "chembl_names": [ "seglitide" ] }, { "inn": "selcopintide", "key": "selcopintide", "chembl": "CHEMBL5095083", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095083/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095083", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=selcopintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=selcopintide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095083" ], "chembl_names": [ "selcopintide" ] }, { "inn": "selepressin", "key": "selepressin", "chembl": "CHEMBL1817709", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1817709/", "stem": "-pressin", "usan_year": 2014, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Vasopressin V1a receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1817709", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=selepressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=selepressin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1817709" ], "chembl_names": [ "selepressin" ] }, { "inn": "semparatide", "key": "semparatide", "chembl": "CHEMBL2103974", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103974/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103974", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=semparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=semparatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103974" ], "chembl_names": [ "semparatide" ] }, { "inn": "seractide acetate", "key": "seractide", "chembl": "CHEMBL1201489", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201489/", "stem": "-tide", "usan_year": 1974, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1978, "encyclopedia": null, "mechanism": [ "Melanocortin receptor 2 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201489", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=seractide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=seractide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201489" ], "chembl_names": [ "seractide acetate" ] }, { "inn": "sermorelin acetate", "key": "sermorelin", "chembl": "CHEMBL1201490", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201490/", "stem": "-relin", "usan_year": 1989, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1990, "encyclopedia": "sermorelin", "mechanism": [ "Growth hormone-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201490", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sermorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sermorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201490" ], "chembl_names": [ "sermorelin acetate" ] }, { "inn": "sinapultide", "key": "sinapultide", "chembl": "CHEMBL2103901", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103901/", "stem": "-tide", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103901", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sinapultide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sinapultide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103901" ], "chembl_names": [ "sinapultide" ] }, { "inn": "solnatide", "key": "solnatide", "chembl": "CHEMBL4297885", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297885/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4297885", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=solnatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=solnatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL4297885" ], "chembl_names": [ "solnatide" ] }, { "inn": "somatorelin", "key": "somatorelin", "chembl": "CHEMBL2108862", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108862/", "stem": "-relin; som-", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108862", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=somatorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=somatorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108862" ], "chembl_names": [ "somatorelin" ] }, { "inn": "sovatelitide", "key": "sovatelitide", "chembl": "CHEMBL3188091", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3188091/", "stem": "-tide", "usan_year": 2020, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3188091", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sovatelitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sovatelitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3188091" ], "chembl_names": [ "sovatelitide" ] }, { "inn": "sucantomotide", "key": "sucantomotide", "chembl": "CHEMBL5314883", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314883/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314883", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sucantomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sucantomotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314883" ], "chembl_names": [ "sucantomotide" ] }, { "inn": "sudocetaxel zendusortide", "key": "sudocetaxel zendusortide", "chembl": "CHEMBL5095153", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095153/", "stem": "-taxel; -tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095153", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sudocetaxel+zendusortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sudocetaxel+zendusortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095153" ], "chembl_names": [ "sudocetaxel zendusortide" ] }, { "inn": "sulglicotide", "key": "sulglicotide", "chembl": "CHEMBL2108085", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108085/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108085", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=sulglicotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=sulglicotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108085" ], "chembl_names": [ "sulglicotide" ] }, { "inn": "tabilautide", "key": "tabilautide", "chembl": "CHEMBL3989637", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989637/", "stem": "-tide", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989637", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tabilautide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tabilautide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989637" ], "chembl_names": [ "tabilautide" ] }, { "inn": "tabimorelin", "key": "tabimorelin", "chembl": "CHEMBL281764", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL281764/", "stem": "-relin", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": "tabimorelin", "mechanism": [ "Ghrelin receptor agonist", "Cytochrome P450 3A4 inhibitor" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL281764", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tabimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tabimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL281764" ], "chembl_names": [ "tabimorelin" ] }, { "inn": "talfirastide", "key": "talfirastide", "chembl": "CHEMBL3545347", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545347/", "stem": "-tide", "usan_year": 2024, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Proto-oncogene Mas agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3545347", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=talfirastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=talfirastide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3545347" ], "chembl_names": [ "talfirastide" ] }, { "inn": "talogreptide mesaroxetan", "key": "talogreptide mesaroxetan", "chembl": "CHEMBL6068177", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068177/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068177", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=talogreptide+mesaroxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=talogreptide+mesaroxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068177" ], "chembl_names": [ "talogreptide mesaroxetan" ] }, { "inn": "taltirelin", "key": "taltirelin", "chembl": "CHEMBL2107016", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107016/", "stem": "-relin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Thyrotropin-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107016", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=taltirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=taltirelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107016" ], "chembl_names": [ "taltirelin" ] }, { "inn": "taspoglutide", "key": "taspoglutide", "chembl": "CHEMBL2107860", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107860/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "taspoglutide", "mechanism": [ "Glucagon-like peptide 1 receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2107860", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=taspoglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=taspoglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2107860" ], "chembl_names": [ "taspoglutide" ] }, { "inn": "tecemotide", "key": "tecemotide", "chembl": "CHEMBL3039544", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3039544/", "stem": "-tide", "usan_year": 2013, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Mucin-1 vaccine antigen" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3039544", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tecemotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tecemotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3039544" ], "chembl_names": [ "tecemotide" ] }, { "inn": "technetium (99mtc) apcitide", "key": "apcitide", "chembl": "CHEMBL1201524", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201524/", "stem": "-tide", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1998, "encyclopedia": null, "mechanism": [ "Diagnostic agent" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201524", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=apcitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=apcitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201524" ], "chembl_names": [ "technetium (99mtc) apcitide" ] }, { "inn": "technetium mertiatide", "key": "technetium mertiatide", "chembl": "CHEMBL2111131", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111131/", "stem": "-tide", "usan_year": 1990, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1990, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2111131", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=technetium+mertiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=technetium+mertiatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2111131" ], "chembl_names": [ "technetium mertiatide" ] }, { "inn": "temurtide", "key": "temurtide", "chembl": "CHEMBL3989635", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989635/", "stem": "-tide", "usan_year": 1989, "molecule_type": "Small molecule", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989635", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=temurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=temurtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989635" ], "chembl_names": [ "temurtide" ] }, { "inn": "teprotide", "key": "teprotide", "chembl": "CHEMBL408983", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408983/", "stem": "-tide", "usan_year": 1976, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL408983", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=teprotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=teprotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL408983" ], "chembl_names": [ "teprotide" ] }, { "inn": "tifuvirtide", "key": "tifuvirtide", "chembl": "CHEMBL2108654", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108654/", "stem": "-tide; -vir-", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108654", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tifuvirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tifuvirtide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108654" ], "chembl_names": [ "tifuvirtide" ] }, { "inn": "tigapotide", "key": "tigapotide", "chembl": "CHEMBL3040192", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3040192/", "stem": "-tide", "usan_year": 2005, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3040192", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tigapotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tigapotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3040192" ], "chembl_names": [ "tigapotide" ] }, { "inn": "tiplimotide", "key": "tiplimotide", "chembl": "CHEMBL2108869", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108869/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108869", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tiplimotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tiplimotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108869" ], "chembl_names": [ "tiplimotide" ] }, { "inn": "tosactide", "key": "tosactide", "chembl": "CHEMBL2103904", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103904/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103904", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tosactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tosactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103904" ], "chembl_names": [ "tosactide" ] }, { "inn": "tozuleristide", "key": "tozuleristide", "chembl": "CHEMBL3990023", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990023/", "stem": "-tide", "usan_year": 2017, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Diagnostic" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3990023", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tozuleristide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tozuleristide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3990023" ], "chembl_names": [ "tozuleristide" ] }, { "inn": "tricosactide", "key": "tricosactide", "chembl": "CHEMBL2103923", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103923/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103923", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tricosactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tricosactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103923" ], "chembl_names": [ "tricosactide" ] }, { "inn": "tridecactide", "key": "tridecactide", "chembl": "CHEMBL2108340", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108340/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108340", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=tridecactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=tridecactide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108340" ], "chembl_names": [ "tridecactide" ] }, { "inn": "triletide", "key": "triletide", "chembl": "CHEMBL2105562", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105562/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2105562", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=triletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=triletide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2105562" ], "chembl_names": [ "triletide" ] }, { "inn": "trofinetide", "key": "trofinetide", "chembl": "CHEMBL197084", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL197084/", "stem": "-tide", "usan_year": 2022, "molecule_type": "Small molecule", "chembl_max_phase": 4.0, "first_approval": 2023, "encyclopedia": null, "mechanism": [ "Unknown" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL197084", "read": "2026-10-01", "active_studies": 1, "most_advanced_active_phase": null, "lead_sponsors": [ "University of Minnesota" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=trofinetide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-06", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT06705816", "url": "https://clinicaltrials.gov/study/NCT06705816", "phase": null, "status": "RECRUITING", "title": "Cognitive Function in Rett Syndrome During Trofinetide Treatment", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL197084" ], "chembl_names": [ "trofinetide" ] }, { "inn": "trolamine polypeptide oleate condensate", "key": "trolamine polypeptide oleate condensate", "chembl": "CHEMBL1201537", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201537/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1958, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201537", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=trolamine+polypeptide+oleate+condensate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=trolamine+polypeptide+oleate+condensate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201537" ], "chembl_names": [ "trolamine polypeptide oleate condensate" ] }, { "inn": "ucasareotide dasaroxetan", "key": "ucasareotide dasaroxetan", "chembl": "CHEMBL5314889", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314889/", "stem": "-tide; -xetan", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314889", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ucasareotide+dasaroxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ucasareotide+dasaroxetan&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314889" ], "chembl_names": [ "ucasareotide dasaroxetan" ] }, { "inn": "ularitide", "key": "ularitide", "chembl": "CHEMBL2103920", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103920/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "ularitide", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2103920", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ularitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ularitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2103920" ], "chembl_names": [ "ularitide" ] }, { "inn": "ulimorelin", "key": "ulimorelin", "chembl": "CHEMBL1963249", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1963249/", "stem": "-relin", "usan_year": 2009, "molecule_type": "Small molecule", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1963249", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ulimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=ulimorelin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1963249", "CHEMBL1923502" ], "chembl_names": [ "ulimorelin", "ulimorelin hydrochloride" ] }, { "inn": "utreglutide", "key": "utreglutide", "chembl": "CHEMBL5095156", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095156/", "stem": "-tide; -treg-", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095156", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=utreglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=utreglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095156" ], "chembl_names": [ "utreglutide" ] }, { "inn": "vanutide cridificar", "key": "vanutide cridificar", "chembl": "CHEMBL2108058", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108058/", "stem": "-tide", "usan_year": 2008, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Amyloid-beta A4 protein vaccine antigen" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL2108058", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vanutide+cridificar&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vanutide+cridificar&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL2108058" ], "chembl_names": [ "vanutide cridificar" ] }, { "inn": "vapreotide", "key": "vapreotide", "chembl": "CHEMBL3349523", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3349523/", "stem": "-tide", "usan_year": 1989, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Somatostatin receptor 2 agonist", "Somatostatin receptor 3 agonist", "Somatostatin receptor 5 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3349523", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vapreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vapreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3349523" ], "chembl_names": [ "vapreotide" ] }, { "inn": "vasoactive intestinal peptide", "key": "vasoactive intestinal peptide", "chembl": "CHEMBL525028", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL525028/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": "vip", "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL525028", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vasoactive+intestinal+peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vasoactive+intestinal+peptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL525028" ], "chembl_names": [ "vasoactive intestinal peptide" ] }, { "inn": "vasopressin tannate", "key": "vasopressin tannate", "chembl": "CHEMBL1201528", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201528/", "stem": "-pressin", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 1982, "encyclopedia": null, "mechanism": [ "Vasopressin V2 receptor agonist", "Vasopressin V1a receptor agonist", "Vasopressin V1b receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL1201528", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vasopressin+tannate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vasopressin+tannate&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL1201528" ], "chembl_names": [ "vasopressin tannate" ] }, { "inn": "veldoreotide", "key": "veldoreotide", "chembl": "CHEMBL3989911", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989911/", "stem": "-tide", "usan_year": 2016, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Somatostatin receptor 2 agonist", "Somatostatin receptor 4 agonist", "Somatostatin receptor 5 agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3989911", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=veldoreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=veldoreotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3989911" ], "chembl_names": [ "veldoreotide" ] }, { "inn": "vensemaglutide", "key": "vensemaglutide", "chembl": "CHEMBL6068314", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068314/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068314", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vensemaglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vensemaglutide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068314" ], "chembl_names": [ "vensemaglutide" ] }, { "inn": "vezocolmitide", "key": "vezocolmitide", "chembl": "CHEMBL6068188", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068188/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068188", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vezocolmitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vezocolmitide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068188" ], "chembl_names": [ "vezocolmitide" ] }, { "inn": "vicatertide", "key": "vicatertide", "chembl": "CHEMBL5314893", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314893/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314893", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vicatertide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vicatertide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314893" ], "chembl_names": [ "vicatertide" ] }, { "inn": "visepegenatide", "key": "visepegenatide", "chembl": "CHEMBL5314895", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314895/", "stem": "-peg-; -tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314895", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=visepegenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=visepegenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314895" ], "chembl_names": [ "visepegenatide" ] }, { "inn": "vorumotide", "key": "vorumotide", "chembl": "CHEMBL5314789", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314789/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5314789", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vorumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vorumotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5314789" ], "chembl_names": [ "vorumotide" ] }, { "inn": "vurolenatide", "key": "vurolenatide", "chembl": "CHEMBL5095367", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095367/", "stem": "-tide", "usan_year": 2021, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095367", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=vurolenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=vurolenatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095367" ], "chembl_names": [ "vurolenatide" ] }, { "inn": "xelafaslatide", "key": "xelafaslatide", "chembl": "CHEMBL6068318", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068318/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068318", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=xelafaslatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=xelafaslatide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068318" ], "chembl_names": [ "xelafaslatide" ] }, { "inn": "zendusortide", "key": "zendusortide", "chembl": "CHEMBL5095162", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5095162/", "stem": "-tide", "usan_year": 2023, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL5095162", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zendusortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=zendusortide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL5095162" ], "chembl_names": [ "zendusortide" ] }, { "inn": "ziconotide", "key": "ziconotide", "chembl": "CHEMBL4594214", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594214/", "stem": "-tide", "usan_year": 1997, "molecule_type": "Protein", "chembl_max_phase": 4.0, "first_approval": 2004, "encyclopedia": "ziconotide", "mechanism": [ "Voltage-gated N-type calcium channel alpha-1B subunit blocker" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL4594214", "read": "2026-10-01", "active_studies": 3, "most_advanced_active_phase": null, "lead_sponsors": [ "Christian Hospital Northeast Northwest", "ESTEVE Pharmaceuticals SAS", "Institut Cancerologie de l'Ouest" ], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=ziconotide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": { "date": "2027-09", "date_type": "ESTIMATED", "state": "upcoming", "overdue": false, "nct": "NCT04321408", "url": "https://clinicaltrials.gov/study/NCT04321408", "phase": null, "status": "RECRUITING", "title": "OP2C : Prialt® Observatory in Clinical Practice", "read": "2026-10-01" }, "no_active_study": null, "pdufa": null, "chembl_ids": [ "CHEMBL4594214", "CHEMBL1795072" ], "chembl_names": [ "ziconotide", "ziconotide acetate" ] }, { "inn": "zifogaptide", "key": "zifogaptide", "chembl": "CHEMBL6068192", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6068192/", "stem": "-tide", "usan_year": null, "molecule_type": "Protein", "chembl_max_phase": 2.0, "first_approval": null, "encyclopedia": null, "mechanism": [], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL6068192", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zifogaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=zifogaptide&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL6068192" ], "chembl_names": [ "zifogaptide" ] }, { "inn": "zoptarelin doxorubicin", "key": "zoptarelin doxorubicin", "chembl": "CHEMBL3544954", "chembl_url": "https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3544954/", "stem": "-relin; -rubicin", "usan_year": 2017, "molecule_type": "Protein", "chembl_max_phase": 3.0, "first_approval": null, "encyclopedia": null, "mechanism": [ "Gonadotropin-releasing hormone receptor agonist" ], "mechanism_source": "https://www.ebi.ac.uk/chembl/api/data/mechanism.json?molecule_chembl_id=CHEMBL3544954", "read": "2026-10-01", "active_studies": 0, "most_advanced_active_phase": null, "lead_sponsors": [], "registry_query": "https://clinicaltrials.gov/api/v2/studies?query.intr=zoptarelin+doxorubicin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "next_readout": null, "no_active_study": { "what": "No active study naming this molecule on ClinicalTrials.gov", "source": "https://clinicaltrials.gov/api/v2/studies?query.intr=zoptarelin+doxorubicin&filter.overallStatus=RECRUITING%2CNOT_YET_RECRUITING%2CACTIVE_NOT_RECRUITING%2CENROLLING_BY_INVITATION&fields=NCTId%2CBriefTitle%2CPhase%2COverallStatus%2CLeadSponsorName%2CPrimaryCompletionDate%2CPrimaryCompletionDateType%2CInterventionName%2CInterventionOtherName%2CCondition&pageSize=100&countTotal=true", "read": "2026-10-01" }, "pdufa": null, "chembl_ids": [ "CHEMBL3544954" ], "chembl_names": [ "zoptarelin doxorubicin" ] } ] }